Intestinal Ca2+ absorption revisited: A molecular and clinical approach by Areco, Vanessa Andrea et al.
World Journal of
Gastroenterology
World J Gastroenterol  2020 June 28; 26(24): 3318-3516
ISSN 1007-9327 (print)
ISSN 2219-2840 (online)
Published by Baishideng Publishing Group Inc
W J G World Journal ofGastroenterology
Contents Weekly  Volume 26  Number 24  June 28, 2020
OPINION REVIEW
3318 Extended lymphadenectomy in hilar cholangiocarcinoma: What it will bring?
Li J, Zhou MH, Ma WJ, Li FY, Deng YL
REVIEW
3326 Non-invasive tests for the prediction of primary hepatocellular carcinoma
Marasco G, Colecchia A,  Silva G, Rossini  B,  Eusebi LH, Ravaioli  F,  Dajti  E,  Alemanni LV, Colecchia L,  Renzulli  M,
Golfieri R, Festi D
3344 Intestinal Ca2+ absorption revisited: A molecular and clinical approach
Areco VA, Kohan R, Talamoni G, Tolosa de Talamoni NG, Peralta López ME
3365 Interventions of natural and synthetic agents in inflammatory bowel disease, modulation of nitric oxide
pathways
Kamalian A, Sohrabi Asl M, Dolatshahi M, Afshari K, Shamshiri S, Momeni Roudsari N, Momtaz S, Rahimi R, Abdollahi M,
Abdolghaffari AH
3401 Long noncoding RNAs in gastric cancer: From molecular dissection to clinical application
Gao Y, Wang JW, Ren JY, Guo M, Guo CW, Ning SW, Yu S
MINIREVIEWS
3413 Ultrasound liver elastography beyond liver fibrosis assessment
Ferraioli G, Barr RG
3421 Recent progress in pulsed electric field ablation for liver cancer
Liu ZG, Chen XH, Yu ZJ, Lv J, Ren ZG
ORIGINAL ARTICLE
Basic Study
3432 Hepatoprotective effects of Hovenia dulcis  seeds against alcoholic liver injury and related mechanisms
investigated via network pharmacology
Meng X, Tang GY, Zhao CN, Liu Q, Xu XY, Cao SY
Retrospective Cohort Study
3447 Comparison of  operative link for  gastritis  assessment,  operative link on gastric  intestinal  metaplasia
assessment, and TAIM stagings among men with atrophic gastritis
Nieminen AA, Kontto J, Puolakkainen P, Virtamo J, Kokkola A
WJG https://www.wjgnet.com June 28, 2020 Volume 26 Issue 24I
Contents
World Journal of Gastroenterology
Volume 26  Number 24  June 28, 2020
3458 Multiphase computed tomography radiomics of pancreatic intraductal papillary mucinous neoplasms to
predict malignancy
Polk  SL,  Choi  JW,  McGettigan  MJ,  Rose  T,  Ahmed A,  Kim J,  Jiang  K,  Balagurunathan Y,  Qi  J,  Farah  PT,  Rathi  A,
Permuth JB, Jeong D
Retrospective Study
3472 Transjugular  intrahepatic  portosystemic  shunt  for  pyrrolizidine  alkaloid-related  hepatic  sinusoidal
obstruction syndrome
Zhou CZ, Wang RF, Lv WF, Fu YQ, Cheng DL, Zhu YJ, Hou CL, Ye XJ
Observational Study
3484 Evaluation of characteristics of left-sided colorectal perfusion in elderly patients by angiography
Zhang C, Li A, Luo T, Li Y, Li F, Li J
SYSTEMATIC REVIEWS
3495 Clinical efficacy of the over-the-scope clip device: A systematic review
Bartell N, Bittner K, Kaul V, Kothari TH, Kothari S
WJG https://www.wjgnet.com June 28, 2020 Volume 26 Issue 24II
Contents
World Journal of Gastroenterology
Volume 26  Number 24  June 28, 2020
ABOUT COVER Editorial Board member of World Journal of Gastroenterology, Guang Ji, MD,
PhD, Chief Doctor, Professor, Institute of Digestive Diseases, Longhua
Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai
200032, China
AIMS AND SCOPE The primary aim of World Journal of Gastroenterology (WJG, World J
Gastroenterol) is to provide scholars and readers from various fields of
gastroenterology and hepatology with a platform to publish high-quality
basic and clinical research articles and communicate their research findings
online.
  WJG mainly publishes articles reporting research results and findings
obtained in the field of gastroenterology and hepatology and covering a
wide range of topics including gastroenterology, hepatology,
gastrointestinal endoscopy, gastrointestinal surgery, gastrointestinal
oncology, and pediatric gastroenterology.
INDEXING/ABSTRACTING The WJG is now indexed in Current Contents®/Clinical Medicine, Science Citation
Index Expanded (also known as SciSearch®), Journal Citation Reports®, Index
Medicus, MEDLINE, PubMed, PubMed Central, and Scopus. The 2019 edition of
Journal Citation Report® cites the 2018 impact factor for WJG as 3.411 (5-year impact
factor: 3.579), ranking WJG as 35th among 84 journals in gastroenterology and
hepatology (quartile in category Q2). CiteScore (2018): 3.43.
RESPONSIBLE EDITORS FOR
THIS ISSUE
Responsible Electronic Editor: Yan-Liang Zhang
Proofing Production Department Director: Yun-Xiaojian Wu
Responsible Editorial Office Director: Ze-Mao Gong
NAME OF JOURNAL
World Journal of Gastroenterology
ISSN












© 2020 Baishideng Publishing Group Inc
INSTRUCTIONS TO AUTHORS
https://www.wjgnet.com/bpg/gerinfo/204
GUIDELINES FOR ETHICS DOCUMENTS
https://www.wjgnet.com/bpg/GerInfo/287












© 2020 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
E-mail: bpgoffice@wjgnet.com  https://www.wjgnet.com
WJG https://www.wjgnet.com June 28, 2020 Volume 26 Issue 24III
W J G World Journal ofGastroenterology
Submit a Manuscript: https://www.f6publishing.com World J Gastroenterol  2020 June 28; 26(24): 3344-3364
DOI: 10.3748/wjg.v26.i24.3344 ISSN 1007-9327 (print) ISSN 2219-2840 (online)
REVIEW
Intestinal Ca2+ absorption revisited: A molecular and clinical
approach
Vanessa A Areco, Romina Kohan, Germán Talamoni, Nori G Tolosa de Talamoni, María E Peralta López








Author contributions: Areco VA,
Kohan R, Talamoni G, Tolosa de
Talamoni NG and Peralta López
ME participated in the collection of
information, analysis, organization
of the information, writing,
preparation of figure and table and
final editing.
Supported by Consejo Nacional de
Investigaciones Cientí ficas y
Tecnoló gicas, Argentina PIP 2017-
2019, No. 11220170100012CO; and
Secretarí a de Ciencia y Té cnica de
la Universidad Nacional de Có
rdoba, Argentina (Programa 2018-
2019), No. 30920180100056CB.
Conflict-of-interest statement: The
authors declare that there are no
conflicts of interest.
Open-Access: This article is an
open-access article that was
selected by an in-house editor and
fully peer-reviewed by external
reviewers. It is distributed in
accordance with the Creative
Commons Attribution
NonCommercial (CC BY-NC 4.0)
license, which permits others to
distribute, remix, adapt, build
upon this work non-commercially,
and license their derivative works
on different terms, provided the
original work is properly cited and
the use is non-commercial. See:
http://creativecommons.org/licen
ses/by-nc/4.0/
Vanessa A Areco, Romina Kohan, Germán Talamoni, Nori G Tolosa de Talamoni, María E Peralta
López, Laboratorio “Dr. Fernando Cañas”, Cátedra de Bioquímica y Biología Molecular,
Facultad de Ciencias Médicas, INICSA (CONICET-Universidad Nacional de Córdoba),
Córdoba 5000, Argentina
Corresponding author: Nori G Tolosa de Talamoni, PhD, Professor, Laboratorio “Dr. Fernando
Cañas”, Cátedra de Bioquímica y Biología Molecular, Facultad de Ciencias Médicas, INICSA
(CONICET-Universidad Nacional de Córdoba), Pabellón Argentina, 2do. Piso, Ciudad
Universitaria, Córdoba 5000, Argentina. ntolosa@biomed.fcm.unc.edu.ar
Abstract
Ca2+ has an important role in the maintenance of the skeleton and is involved in
the main physiological processes. Its homeostasis is controlled by the intestine,
kidney, bone and parathyroid glands. The intestinal Ca2+ absorption occurs
mainly via the paracellular and the transcellular pathways. The proteins involved
in both ways are regulated by calcitriol and other hormones as well as dietary
factors. Fibroblast growth factor 23 (FGF-23) is a strong antagonist of vitamin D
action. Part of the intestinal Ca2+ movement seems to be vitamin D independent.
Intestinal Ca2+ absorption changes according to different physiological conditions.
It is promoted under high Ca2+ demands such as growth, pregnancy, lactation,
dietary Ca2+ deficiency and high physical activity. In contrast, the intestinal Ca2+
transport decreases with aging. Oxidative stress inhibits the intestinal Ca2+
absorption whereas the antioxidants counteract the effects of prooxidants leading
to the normalization of this physiological process. Several pathologies such as
celiac disease, inflammatory bowel diseases, Turner syndrome and others occur
with inhibition of intestinal Ca2+ absorption, some hypercalciurias show Ca2+
hyperabsorption, most of these alterations are related to the vitamin D endocrine
system. Further research work should be accomplished in order not only to know
more molecular details but also to detect possible therapeutic targets to
ameliorate or avoid the consequences of altered intestinal Ca2+ absorption.
Key words: Ca2+ absorption; Transcellular pathway; Paracellular pathway; Hormones;
Dietary calcium; Physiological conditions; Pathological alterations
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Core tip: The intestinal Ca2+ absorption occurs mainly via the paracellular and the
transcellular pathways. Both ways are regulated by calcitriol and other hormones as well
as dietary factors. Fibroblast growth factor 23 (FGF-23) is a strong antagonist of vitamin
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D action. Part of the intestinal Ca2+ movement seems to be vitamin D independent.
Intestinal Ca2+ absorption changes according to different physiological conditions.
Oxidative stress inhibits the intestinal Ca2+ absorption whereas the antioxidants
counteract the prooxidant effects. Most diseases that occur with altered intestinal Ca2+
absorption is related to changes in the vitamin D endocrine system. Further research
could clarify many unknown points in this subject.
Citation: Areco VA, Kohan R, Talamoni G, Tolosa de Talamoni NG, Peralta López ME.





Ca2+ plays a relevant role in the skeleton, being the bones the storage site of 99% of
total body Ca2+, mainly in the form of hydroxyapatite crystals[1]. Ca2+ is essential for
the acquisition of an optimal peak bone mass within the first two decades, as well as
for  the  maintenance of  bone mineral  density  (BMD) in  adulthood[2].  Apart  from
skeletal mineralization, this divalent cation is an important intracellular messenger
and it actively participates in multiple physiological functions such as nerve excitation
and transmission, muscle and cardiac contraction, blood coagulation, gland secretion
and enzyme activation, among others. It is also implicated in cell differentiation and
apoptosis  as  well  as  in  immune  response,  thus  having  a  significant  role  in
tumorigenesis and cancer development[3]. This vast scope of functions raises the need
for a homeostatic regulatory system. Extracellular and metabolic Ca2+ homeostasis is
achieved by the concerted action of several Ca2+ regulating hormones: Parathyroid
hormone (PTH), 1,25(OH)2D3 or calcitriol and calcitonin (CT). Estrogen, insulin-like
growth factor (IGF-1),  prolactin (PRL) and fibroblast growth factor (FGF-23) also
participate in Ca2+ regulation[4].
Intestinal absorption is the unique way for Ca2+ to enter the organism from dietary
nutrients. It occurs via two different mechanisms. When luminal Ca2+ is higher than
that  in  the  plasma,  Ca2+  predominantly  enters  the  intestine  via  the  paracellular
pathway  through  tight  junctions  between  neighbouring  enterocytes[5].  This  is  a
passive  non saturable  transport,  which  takes  place  all  along the  small  intestine
without significant variations. In contrast, when luminal Ca2+ is lower than plasmatic
Ca2+, the cation is actively absorbed via the transcellular pathway, which is an active
saturable system that prevails in the duodenum[5,6]. Both mechanisms are regulated by
different endocrine and non-endocrine factors.
Intestinal Ca2+ absorption in humans reaches approximately 35% of dietary load[7].
The amount of Ca2+ absorbed mainly depends on the quantity of Ca2+ consumed, the
transit time in different parts of the gut and the solubility of Ca2+, which is inversely
related  to  luminal  pH[8].  Even  though  the  absorption  is  more  efficient  in  the
duodenum and jejunum, where pH is lower, the amount of Ca2+ absorbed is greater in
the ileum, since intestinal content remains ten times longer in this portion, which is
finally responsible for almost 65% of Ca2+ absorption[9].
MOLECULAR MECHANISMS OF INTESTINAL Ca2+
ABSORPTION
Paracellular pathway
This absorptive route comprises the entrance of Ca2+  through electrically-charged
watery space delimited by two neighbouring enterocytes. As it is the result of passive
diffusion, this movement of the cation depends on Ca2+ concentration and voltage
across intestinal epithelium. Rats fed a Ca2+-replete diet and humans show a chemical
gradient which is favorable to the inward movement of the cation, since free Ca2+ is
present in the duodenal lumen in a concentration of 2-6 mmol/L, compared to the
much lower concentration in the interstitial fluid or plasma (1.25 mmol/L)[9,10]. As to
electrical  potential,  the plasma is  positive compared to the lumen,  which would
determine  a  secretion  movement  and  exit  of  Ca2+.  However,  since  this  voltage
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gradient  is  very  low,  (2.5  mV),  there  is  no  outward  flow  of  the  cation  due  to
electrodiffusion[11]. Apart from chemical gradient, Ca2+ together with other ions and
small hydrophilic molecules enter through paracellular space along with the stream of
water. This solvent drag-induced mechanism depends on the activation of sodium-
glucose co-transporter 1 (SGLT-1) and Na+/K+-ATPase. Sodium, which enters through
SGLT-1  and  other  sodium-coupled  apical  transporters,  is  pumped  into  the
paracellular  space  by  Na+/K+-ATPase,  thus  increasing  sodium  paracellular
concentration and consequently augmenting osmotic water flow through this space.
For  this  reason  luminal  glucose  and  galactose,  which  are  substrates  of  SGLT-1,
increase duodenal Ca2+ absorption[12]. Finally, duodenal epithelium has a preferential
selectivity for small mono or divalent cations, such as Na+  or Ca2+,  over larger or
negative  ions.  This  selectivity  depends  on  some  proteins  such  as  occludin  and
claudins (CLDNs) in the tight junctions, which are specialized membrane domains in
the apical region of enterocytes. CLDNs 2, 12, and 15 are associated with intestinal
Ca2+ entering[13,14]. CLDNs 1 and 5 have sealing functions that could also diminish Ca2+
transport[15,16]. The expression of four candidate genes of the paracellular pathway,
CLDN2 and tight junction proteins 1, 2, and 3, has been shown to be enhanced in the
small intestine of laying hens after sexual maturity[6].
Transcellular pathway
This  active  transport  is  carried  out  in  three  main  steps;  firstly,  Ca2+  enters  the
enterocytes  passively  across  the  apical  membranes.  Afterwards,  it  binds  to
intracytoplasmatic proteins, which transfer the cation to the basolateral membrane
(BLM). Finally, plasma membrane Ca2+-ATPase (PMCA1b) is the main Ca2+ transporter
that extrudes the cation by primary active transport, at the expense of stored ATP.
Entrance of Ca2+ across the brush border membrane
Brush border membrane (BBM) is the first barrier that Ca2+ has to overcome in its way
from intestinal lumen into the blood. Since Ca2+ is not able to move freely across the
lipid bilayer of the plasma membrane, intestinal absorptive cells express some Ca2+
transporters. There are two epithelial Ca2+ channels that favor the passive transport of
the cation across the apical membrane into enterocyte cytoplasm: Transient receptor
potential vanilloid 5 (TRPV5) also known as ECaC1 or CaT2, and transient receptor
potential  vanilloid  6  (TRPV6);  also  known as  ECaC2 or  CaT1[2].  TRPVs are  very
important for maintaining blood Ca2+ levels in higher organisms, humans included.
They are localized in apical membrane of Ca2+-transporting epithelial tissues and
respond to 1,25(OH)2D3. They are structurally very similar since they share 75% of
aminoacid identity. However, they differ in their distribution: TRPV5 expression is
almost restricted to the kidney[17] and determines the level of urinary excretion of Ca2+
whereas TRPV6 shows intense expression in the intestine, thus being particularly
important in intestinal Ca2+ absorption. More ubiquitously expressed, TRPV6 is also
present  in  the  kidney,  placenta,  epididymis  and  exocrine  glands  among  other
tissues[17,18]. Apical entrance of Ca2+ through TRPV6 is warranted by the favourable
inwardly oriented electrochemical  gradient  for  Ca2+,  usually in low intracellular
concentrations (100 nmol/L)[19].
Although TRPV6 is central for active Ca2+ absorption, studies in TRPV6 KO-mice
have demonstrated that some Ca2+ is still absorbed when TRPV6 is absent[20]. Even
more, the stimulating effect of 1,25(OH)2D3 on intestinal Ca2+ absorption is partially
preserved in these animals[21]. In the same line, Woudenberg-Vrenken et al[22] obtained
similar results when evaluating transepithelial Ca2+  absorption in a mouse-model
carrying a nonfunctional TRPV6. They found that mice experimentally modified in
one critic aminoacid residing in the pore site of the channel had lower intestinal Ca2+
uptake  than  wild-type  controls  and  interestingly,  showed  a  compensatory
upregulation of TRPV5; however, insufficient to completely correct the diminished
Ca2+  absorption.  These findings strongly suggest that some other molecules may
participate in the apical crossing of the electrolyte.
Another type of Ca2+ channel is present in the surface of enterocytes, Cav1.3, an
apical L-type voltage-dependent channel present from the duodenum to the ileum,
which might have a complementary role in Ca2+  permeation through TRPV6. The
latter channel predominates in the duodenum, is activated by hyperpolarization,
mainly overnight and between meals, and depends on vitamin D. In contrast, Ca(v)
1.3, predominates in mid-ileum, is activated when membrane is depolarized, mainly
during postprandial active digestion, and is not modulated by vitamin D[23].
Intracellular Ca2+ crossing from apical to BLM
Once Ca2+ has passively entered the enterocyte, it binds to calbindins (CBs) and is
subsequently transferred to BLM. All these proteins have a high α-helical content and
share EF-hand structures with a helix-loop-helix sites that constitute the Ca2+-binding
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domains.  These  EF-hand  motifs  are  held  together  in  a  single  globular  fold  via
hydrophobic interactions[24]. CB9k is present in the intestine of mammals, being highly
abundant  in  the  duodenum  and  gradually  decreasing  downwardly  to  become
undetectable in distal ileum and colon[25]. CBs belong to a superfamily of Ca2+-binding
proteins that also includes calmodulin and troponin C[26]. It has been shown that CB28K
undergoes structural changes upon Ca2+ binding, which is indicative of a Ca2+-sensing
protein[27].
Even though Ca2+ can cross the aqueous cytoplasmic environment at a higher rate
than when associated with proteins[28], its binding to CBs prevents the free flow of
Ca2+, helping to maintain intracellular Ca2+ lower than 10-7 mol/L. This Ca2+ buffering
is extremely important since it prevents the potential deleterious pro-apoptotic effect
of the cation, which has been confirmed in different tissues[29].
Since  excessive  free-ionized  Ca2+  next  to  the  BBM  could  deactivate  TRPV6
restricting  Ca2+  entry,  the  Ca2+  transferring  function  of  these  proteins  may  also
contribute to warranting a persistent Ca2+ entry through the apical membrane[30]. In
this  direction,  Song  et  al[31]  have  found that  both  TRPV6  and  CB9k  are  similarly
regulated, both being induced at weaning or under low Ca2+diets.
The expression of CB9k in duodenal enterocytes strongly depends on 1,25(OH)2D3[32],
as also does the expression of other Ca2+-binding proteins such as CB28k, calmodulin,
parvalbumin and sorcin[33],  although the significance of their contribution to Ca2+
transferring remains to be specified. However, similarly to what we have referred for
TRPV6,  CB9k-KO  mice  partially  preserve  Ca2+  translocation  capacity[20],  which
reinforces the potential role in cytoplasmatic Ca2+ translocation of several proteins
other than CB9k. In this sense, Teerapornpuntakit et al[34] have found an upregulation
of CB28k and parvalbumin expression in pregnancy and lactation, as a complementary
mechanism to supply for the high demand of Ca2+ in these physiological conditions.
Hwang et al[35]  have observed an increase in the expression of most tight junction
genes  in  the  duodenum  of  normally  fed  CB9k-KO  mice  compared  to  wild-type
controls. These findings suggest that the transcellular Ca2+-binding proteins may also
exert some regulatory effect on paracellular Ca2+ absorption, suggesting that active
and passive Ca2+ transport pathways may function cooperatively.
Ca2+exit across the BLM
The active Ca2+ transport is required to overcome the unfavourable electrochemical
gradient for Ca2+ across the BLM. PMCA1b and Na+/Ca2+ exchanger (NCX1) are the
two proteins in charge of extruding Ca2+ out of the enterocyte, thus completing the
transcellular Ca2+absorption.
PMCA1b,  responsible for almost 80% of Ca2+  extrusion[36],  is highly active in the
duodenum, as detected in rats and it is a primary active transporter able to hydrolyze
directly ATP to transport the cation[37]. The expression and activity of this pump is
higher  in  enterocytes  from the tip  of  the villi  than in  those from the crypt.  This
difference  goes  in  line  with  the  concept  that  mature  enterocytes  show a  greater
efficiency in transcellular Ca2+ movement[38]. NCX1, in contrast, is a secondary active
transporter, coupled with Na+/Ca2+-ATPase, which creates a sodium gradient for
NCX1-mediated Ca2+ efflux. It has a Na+/Ca2+ stoichiometry of 3:1 and it can either
extrude or intrude Ca2+depending on cation gradients and the potential across the
plasma  membrane[39].  It  appears  to  be  responsible  for  approximately  20%  of
basolateral uphill Ca2+ extrusion from the enterocyte into blood stream[37]. Despite the
importance  of  NCX1 in  several  tissues  such as  cardiac  muscle,  vascular  smooth
muscle and the nerves[40-42], the lower implication of this transporter in Ca2+ absorption
as  compared  to  PMCA1b  activity  caused  NCX1 to  be  neglected  in  many studies
concerning the intestine.
Basolateral Ca2+ absorption is closely related to the uptake of the cation in the apical
membrane and its  intracellular  translocation.  In  this  sense,  a  linear  relationship
between apical uptake and PMCA activity has been found in the duodenum of male
rats[43]. In addition, CB9k and CB28k, calmodulin and parvalbumin activate PMCA[44,45].
This concerted mechanism contributes to avoiding intracellular accumulation of Ca2+,
which would block Ca2+ entry from the lumen and could lead to apoptosis.
REGULATION OF INTESTINAL CALCIUM ABSORPTION
Hormonal regulation of calcium absorption
Vitamin D: 1,25(OH)2D3, the active metabolite of vitamin D, is the main regulating
hormone  of  intestinal  Ca2+  absorption.  It  induces  structural  and  functional
modifications in enterocytes and helps to enhance both transcellular and paracellular
pathways, either by genomic or nongenomic actions[46,47]. 1,25(OH)2D3 can reach the
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intestinal target coming from two different sources: Either from the plasma, once its
synthesis  has  been completed by  25(OH)D3 1α-hydroxylase  (CYP27B1)  in  renal
proximal tube (endocrine source)[48] or from de novo synthesis in the cytoplasm of the
enterocyte, performed by a duodenal 1α-hydroxylase (intracrine source)[49].
This calciotropic lipophilic  vitamin passes through the plasma membrane and
binds to vitamin D receptor (VDR), its nuclear receptor. Once bound to the ligand,
VDR forms a heterodimer with retinoid X receptor (RXR) and the new 1,25(OH)2D3-
VDR-  RXR complex  functions  as  a  transcription  factor  which  binds  to  different
vitamin D response elements in various target genes[50]. This determines a significant
increase in the expression of all Ca2+ transporting proteins in the enterocyte: TRPV 6,
CB9K,  PMCA1b  and  NCX1,  as  has  been  demonstrated  in  animal  models  and
humans[2,4,49,51-54]. Vitamin D-mediated Ca2+ absorption has mainly been studied in the
proximal intestine, where Ca2+ is more efficiently absorbed. However, Christakos et
al[30] have recently studied this process in mice with transgenic expression of VDR
exclusively in the ileum, cecum and colon of  VDR KO mice.  Interestingly,  these
animals  did  not  present  the  abnormalities  in  Ca2 +  homeostasis  and  bone
mineralization  usually  seen  in  VDR  KO  mice.  These  findings  emphasize  the
importance of 1,25(OH)2D3-mediated Ca2+ absorption in the distal intestine[55].
Apart  from  these  Ca2+-transporting  proteins,  1,25(OH)2D3  can  regulate  other
important genes in Ca2+ metabolism, such as the one of 24-hydroxylase (CYP24A1)
which converts 1,25(OH)2D3 into 1,24,25(OH)3D3 and 25(OH)D3 into 24,25(OH)2D3, and
CYP27B1, involved in the renal synthesis of 1,25(OH)2D3[56], but also expressed in the
intestine[57] and parathyroid gland[58].
In  addition  to  the  genomic  action  described,  there  is  some  evidence  that
1,25(OH)2D3  also  binds  to  a  plasma  membrane  receptor  (MARRS:  Membrane-
associated, rapid response steroid-binding protein), which, in turn, activates other
second messenger  systems such as  phospholipase  A2 and protein  kinase  C[59-61].
Details of the underlying molecular mechanism of 1,25(OH)2D3-MARRS and its rapid
minute-to-minute regulatory capacity remain to be elucidated.
Even  though  the  transcellular  pathway  has  been  the  focus  of  most  studies
concerning the effect of calcitriol on intestinal Ca2+ absorption, vitamin D has proved
to exert a positive effect on the paracellular absorptive route as well. 1,25(OH)2D3 is
able to change the permeability and selectivity of  the tight  junctions by altering
certain crucial proteins such as CLDNs 2 and 12. This would help to enhance passive
diffusion of Ca2+[62].
Rexhepaj et al[63] have observed that 1,25(OH)2D3 could also stimulate Na+/Ca2+-
ATPase and SGLT, and consequently increase water-movement through the junction,
thus carrying more Ca2+ inwardly with the flow. Tudpor et al[64] have demonstrated a
dose dependent increase in solvent drag-induced Ca2+ movement one hour after direct
exposure  of  rats  to  10-100  nmol/L  1,25(OH)2D3.  This  rapid  effect,  abolished  by
inhibitors of phosphatidylinositol 3-kinase, protein kinase C, and MEK, would be
mediated by nongenomic mechanisms involving 1,25(OH)2D3-MARRS.
It has also been reported that 1,25(OH)2D3 downregulates intestinal cadherin-17
(involved in cell-to-cell contact) and aquaporin-8 (associated with epithelial selectivity
towards cations), which might also affect the Ca2+ absorption[20,65].
PTH: PTH, a hypercalcemic hormone secreted by parathyroid glands, is the other
classical  hormone known to  exert  a  positive  regulatory  effect  on  intestinal  Ca2+
absorption. However, this stimulatory effect is achieved indirectly after increasing
CYP27B1 transcription for  1α-hydroxylase,  the renal  enzyme that  completes  the
synthesis of 1,25(OH)2D3 in the kidney. As a result, 1,25(OH)2D3 production augments.
In addition, PTH also suppresses the transcription of CYP24A1 that codifies for 24-
hydroxylase,  a  renal  enzyme which  degrades  1,25(OH)2D3  by  converting  it  into
1,24,25(OH)3D3[66]. Both actions lead to an increase in plasmatic 1,25(OH)2D3, which in
turn enhances Ca2+ absorption as we have already revised.
Thyroid hormones: Thyroxine (T4) and triiodothyronine (T3) are known to regulate
metabolism in general. Overproduction of T4 or T3 in the context of hyperthyroidism
can lead to hypercalcemia due to an excessive bone turnover and consequently lead to
bone demineralization[67,68]. However, there is some evidence that thyroid hormones
would cooperate with vitamin D by increasing the genomic actions of 1,25(OH)2D3 in
the intestine[69]. Cross et al[70] have shown that calcitriol added to cultures of 20-day-old
embryonic  chick small  intestine,  stimulated Na+  uptake.  The calcitriol-mediated
increase  in  Na+  uptake  appeared  to  be  related  to  increased  tight-junctional  or
paracellular  permeability[70].  It  can be speculated that  this  effect  could favor  the
paracelullar entry of Ca2+ as well. More recently, Kumar et al[71] have shown that Ca2+
influx in BBM vesicles was higher in enterocytes from hyperthyroid rats as compared
to those of hypothyroid ones. The authors have proposed that this could be related to
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a change in membrane fluidity induced by thyroid hormones. Similarly, they have
also observed that efflux of calcium across BLM was also higher in hyperthyroid rats.
This difference was associated with a higher NCX1 activity triggered by thyroid
hormones, possibly through the cAMP-mediated pathway. cAMP is a potent activator
of  Na+/Ca2+  exchanger  and  it  was  significantly  higher  in  intestinal  mucosa  of
hyperthyroid rats as compared to euthyroid animals. In addition to these actions,
thyroid treatment increases serum PTH and 1,25(OH)2D3 levels, which contributes to
enhancing Ca2+ absorption indirectly through vitamin D[7].
Growth hormone:  Growth hormone (GH) has a central role in longitudinal bone
growth  and  mineralization  during  childhood  and  adolescence.  However,  this
metabolic hormone has receptors in most tissues and exerts various actions apart from
skeletal  growth.  There is  evidence that GH has proliferative effects  on intestinal
mucosa[72]. GH has been used to treat inflammatory bowel disease in pediatric[73] and
adult patients[74]. Interestingly, FDA has approved the use of recombinant human GH
to treat short bowel syndrome, where it improves absorption of carbohydrates, amino
acids and fats[75,76].  GH can also stimulate intestinal Ca2+  absorption, which would
occur indirectly by activating renal CYP27B1 and consequently increasing serum
1,25(OH)2D3  levels[77].  It  has  been demonstrated that  GH can prevent  the  loss  of
intestinal VDR in ovariectomized (OVX) rats[78], which would suggest that it could
increase  intestinal  sensitivity  to  1,25(OH)2D3  by  regulating  tissue  VDR levels[79].
However,  the positive effect  of  GH on Ca2+  absorption would not be exclusively
dependent on vitamin D. Fleet et al[80] have shown that GH increases intestinal Ca2+
absorption  and  duodenal  CB9k  levels  in  aged  rats  without  increasing  serum
1,25(OH)2D3 levels. Analogous results have been found in humans. In adult men, Ca2+
absorption has a positively correlation with IGF-1 and age-related decline in IGF-1 has
a negative impact on Ca2+ absorption that could not be justified by a decrease in serum
1,25(OH)2D3[81].
Estrogens: There is evidence that post-menopausal women experiment an increase in
bone resorption together  with a  reduction in Ca2+  absorption and an increase in
urinary Ca2+ excretion as a consequence of estrogen loss[82,83]. Post-menopausal low
estrogen levels have been associated with reduced serum 1,25(OH)2D3[84]. However,
OVX rats have no reduction in serum 1,25(OH)2D3 levels[85], which would suggest the
implication of vitamin D independent mechanisms. Thus, O’Loughlin et al[86] observed
that estradiol replacement in OVX rats increases intestinal Ca2+ absorption without
stimulation of circulating 1,25(OH)2D3 levels. In the same line, van Abel et al[87] found
increased duodenal gene expression of TRPV5, TRPV6, CB9k, and PMCA1b in OVX
rats treated with estradiol. In order to determine whether this stimulatory effect on
Ca2+ transporting proteins was calcitriol-dependent, they used CYP27B1 KO mice and
found  that  estradiol  treatment  increased  mRNA  levels  of  duodenal  TRPV6.  In
contrast,  Gennari  et  al[88]  found that  oophorectomy in young women reduces the
intestinal Ca2+absorption induced by vitamin D, which was reversed by estrogen
repletion. Other studies suggest the possibility of a deficient intestinal responsiveness
to vitamin D due to a reduction of VDR levels[78,89,90]. However, the loss of intestinal
VDR levels following estrogen reduction could not be confirmed in all studies[91].
Cell-culture experiments suggest that estrogen is able to reverse the decline in the
efficiency of intestinal Ca2+ absorption at menopause onset[92], but the mechanisms that
underlie this effect remain to be elucidated. Estrogen receptor alpha (ERα) KO mice
showed a decrease in duodenal TRPV6 mRNA expression, without modification in
CB9k, PMCA1b and VDR levels. Therefore, it seems that the genomic effects of estrogen
on mice intestinal mucosa are mainly mediated by ERα[93]. However, Nie et al[94] have
recently  reported  that  estrogen  regulates  duodenal  Ca2+  absorption  through
differential effects of ERα and ERβ on TRPV6 and PMCA1b expressions in duodenal
epithelial cells, respectively.
PRL: The main lactogenic hormone, PRL, is elevated during pregnancy and lactation.
Apparently, this pituitary hormone is able to enhance Ca2+  absorption in order to
supply calcium for milk production. It has been shown that PRL enhances CYP27B1
protein expression and increases levels of 1,25(OH)2D3 during lactation, a moment
when  there  is  an  increased  Ca2+  requirement  for  the  neonate[95].  However,  its
calciotropic action is not only achieved via vitamin D. It has been shown that PRL
stimulates  active  intestinal  Ca2 +  transport  in  vitamin  D-deficient  rats [ 9 6 ].
Charoenphandhu et al[11] demonstrated that PRL directly stimulates active duodenal
Ca2+ transport. Wongdee et al[97] observed that lactating rats exhibit some adaptive
changes in their intestinal mucosa tending to increase the absorptive surface area.
These rats have larger duodenal, jejunal and ileal villous as well as deeper cecal crypts
than age-matched nulliparous rats. These histological modifications were diminished
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by bromocriptine, an inhibitor of pituitary PRL release. PRL also upregulated TRPV6
and PMCA1b in the duodenum of lactating rats. These changes were associated with a
compensatory  increase  in  FGF-23  expression,  a  local  negative  regulator  of  Ca2+
absorption, presumably to prevent Ca2+ hyperabsorption. Bromocriptine also manages
to abolish FGF-23 increment, confirming it was induced by PRL. In addition, it has
been suggested that PRL has also a stimulating effect on paracellular pathway by
upregulating CLDN 15 in the tight junctions[98].
FGF-23: It is a glycoprotein secreted by osteocytes and osteoclasts and regulated by
plasma levels of 1,25(OH)2D3 and Pi. The enhancement of these regulators leads to the
serum increase in FGF-23, which in turn reduces the concentration of 1,25(OH)2D3 by
inhibiting  1α-hydroxylase  and  stimulating  24  α-hydroxylase.  As  for  Pi,  FGF-23
increases its renal excretion[99].
FGF-23 has been indicated as a vitamin D antagonist in intestinal absorption of
Ca2+. Khuituan et al[32] have demonstrated that intravenous administration of FGF-23
to male rats abolished the increase in intestinal absorption of Ca2+  caused by the
injection  of  1,25(OH)2D3.  However,  the  inhibitory  effect  of  FGF-23  could  not  be
observed in the absence of the previous supply of 1,25(OH)2D3.  The mechanisms
underlying  the  effect  of  FGF-23  would  be  related  to  the  decrease  in  the  gene
expression of TRPV5, TRPV6 and CB9k caused by this phosphaturic hormone. In this
same work, the presence of FGFR1-4 in the BLM of rat enterocytes was confirmed.
However,  their  functions  are  unclear  since  the  direct  exposure  of  the  intestinal
epithelium to FGF-23 did not cause alterations.
FGF-23  also  blocks  the  stimulatory  effect  of  1,25(OH)2D3  on  the  paracellular
pathway of  intestinal  Ca2+  absorption[100].  Since vitamin D favors this  process by
increasing water flow across paracellular space and consequently dragging solutes as
Ca2+,  it  has  been  proposed  that  FGF-23  could  decrease  the  water  flow  and  the
dragging of this cation.
The activation of the mechanisms mediated by FGF-23 would be crucial to avoid
the Ca2+  hyperabsorption. Therefore, it  was thinkable that a molecule that senses
extracellular Ca2+ as the calcium sensing receptor (CaSR) would play an important
role.  In  fact,  Rodrat  et  al[101]  have  demonstrated  that  CaSR  was  involved  in  the
inhibition  of  intestinal  Ca2+  absorption  mediated  by  FGF-23.  According  to  their
findings in a cell monolayer, the use of allosteric inhibitors of CaSR could reverse the
inhibitory  effect  of  FGF-23  on  the  stimulation  of  Ca2+  transport  triggered  by
1,25(OH)2D3.
Glucocorticoids: The negative side effects of glucocorticoid (GC) treatment on bone
health are well known. Impaired function and number of osteoblasts and osteoclasts,
high resorption rate, deficiency in mineralization are some of the effects of chronic
treatment that lead to the development of GC-induced osteoporosis (GIO)[102]. GIO is
also partially due to the alterations that GC produces in intestinal Ca2+ absorption.
Van Cromphaut et al[103] evaluated the effect of dexamethasone treatment on the gene
expression of proteins involved in the intestinal absorption of the cation. They did not
find alterations in gene expression or Ca2+ absorption in the treated mice, justifying
the absence of effects with the short treatment duration. Kim et al[104] determined that a
single dose of dexamethasone increased the gene expression of TRPV6 and CB9k,
while when it was given for 5 days, it led to a reduction in the expression of both
genes. In concordance with these results, mRNA levels for duodenal VDR increased
on  day  one,  while  they  were  reduced  after  5  days  of  treatment.  Zhang  et  al[105]
observed reduced protein expression of TRPV6 and CB9k in the intestine of male mice
injected  with  dexamethasone  3  times  a  week,  for  12  weeks,  effect  that  was
accompanied by hypercalciuria and reduction in serum Ca2+ levels. Although the role
of GC in intestinal Ca2+ absorption is not clear, the results presented would allow infer
a certain negative effect of GC on cation transfer from the lumen to the interstitium.
CT: The role of CT on intestinal Ca2+absorption is controversial. Some studies have
suggested  that  CT  inhibits  the  process;  in  contrast,  others  indicate  that  has  a
stimulatory effect. Swaminathan et al[106] have demonstrated that CT may produce an
inhibitory  effect  at  low  doses,  whereas  high  doses  increase  the  intestinal  Ca2+
absorption. CT effect could be mediated by the vitamin D endocrine system, since it
has been demonstrated in diabetic rats that CT increases 1,25(OH)2D3  synthesis at
renal level[107].  Use of CT has been suggested to treat patients with β-thalassemia
because they usually have low plasma levels of this hormone. CT chronic use has
benefited osteoporosis associated with thalassemia, not only for its inhibitory effect on
osteoclasts but also for the possible role in the 1,25(OH)2D3 synthesis[108].
Regulation of intestinal Ca2+ absorption by dietary calcium
The main dietary factor that can modify intestinal Ca2+ absorption is calcium itself.
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Low-calcium uptake could eventually produce hypocalcemia, which would augment
PTH secretion leading to stimulate vitamin D endocrine system and demineralize
bone[109]. On the other hand, high calcium diets and calcium hyperabsorption could
increase cardiovascular risk associated with vascular calcification, nephrolithiasis and
dementia, among other conditions[110,111]. Since the gut is the only gate for Ca2+ uptake,
it is subjected to both local and systemic regulations, which protect against either
insufficient or excessive Ca2+ absorption[112]. Low calcium diets enhance serum levels
of vitamin D and, consequently, activate the endocrine actions of this vitamin. Thus, a
chronic  dietary  Ca2+  deficiency  increases  all  transcellular  pathway  genes  and
proteins[109,113,114],  and increases the activity of the intestinal PMCA1b  and NCX1 all
along the villus, independently of cell maturation degree[38]. Benn et al[20] have gone
further to demonstrate that this adaptive increase in Ca2+ absorption is present even in
TRPV6 KO and CB9k KO mice, suggesting that TRPV6, which has been postulated as
the  rate-limiting  factor  in  transcellular  pathway,  may  not  be  so  or  it  may  be
successfully replaced by other factors able to partially compensate its function. In our
laboratory, we have observed in animals under low Ca2+ diets that the increment in
Ca2+ transport is accompanied by a concomitant increase in the activity of intestinal
alkaline phosphatase (IAP), a marker enzyme of enterocytic differentiation that may
have a role in intestinal Ca2+ absorption[38]. Brun et al[115] have reported that luminal
Ca2+  concentration increases the activity of IAP and simultaneously decreases the
percentage of Ca2+  absorption, functioning as a minute-to-minute local regulatory
mechanism of Ca2+ entry, independent of vitamin D. This would limit an excessive
Ca2+ intake secondary to dietary calcium restriction, thus preventing possible acute
toxic effects. This regulatory mechanism may probably be one of the reasons why
high Ca2+  intake (1500 mg/d) was not  followed by a  significant  increase in  Ca2+
absorption in a clinical trial[116,117], as it would have been expected from the positive
effect of stimulated vitamin D endocrine system. Interestingly, L-Phenylalanine, an
inhibitor of IAP, prevented this regulatory effect and Ca2+ uptake remained increased.
A  more  recent  study  showed  that  IAP  activity  induced  by  luminal  calcium
concentration provoked changes in luminal pH that could modulate intestinal Ca2+
absorption[118]  In addition, a recent study revealed that IAP KO mice have higher
intestinal  Ca2+  uptake,  which correlates  with  better  biomechanical  properties  of
trabecular bone[119].
It  has  also  been  suggested  that  CaSR,  abundantly  expressed  in  apical  and
basolateral  membranes  of  enterocytes  in  humans,  rats  and  mice[120-122]  may  also
participate in the local  regulation of  intestinal  Ca2+  absorption.  Intestinal  CaSR -
specific KO mice showed an altered intestinal integrity, disbalanced gut microbiota
and a pro-inflammatory status[123-125]. Rodrat et al[101] have recently observed that high-
dose of 1,25(OH)2D3 or high concentration of luminal calcium reduced Ca2+ transport
across a Caco-2 monolayer. The authors proposed that CaSR would sense luminal
calcium triggering a local inhibitory feedback mechanism to restrict excessive Ca2+
uptake[101].  This  inhibitory loop could possibly involve locally produced FGF-23,
which has been observed to counteract the enhanced duodenal Ca2+ transport in mice
exposed to 1,25(OH)2D3 for a long term[32,100].
INTESTINAL Ca2+ ABSORPTION UNDER DIFFERENT
PHYSIOLOGICAL CONDITIONS
Intestinal Ca2+ absorption changes according to the different physiological conditions.
It is promoted under high Ca2+ demands such as growth, pregnancy, lactation, dietary
Ca2+ deficiency and high physical activity. In contrast, the intestinal Ca2+ transport
decreases with aging.
Growth
In small and premature infants, who need higher dietary calcium to have a positive
balance, the intestinal Ca2+ absorption occurs through a passive paracellular pathway.
These infants are unable to upregulate the transcellular pathway[126]. A progressive
declination in the predominance of the paracellular pathway has been observed from
childhood to adulthood[127]. Similarly, in rodents the intestinal Ca2+ absorption changes
with age in order to reach the requirements for bone mineralization during growth. In
suckling rat, the intestinal Ca2+ transport occurs predominantly through paracellular
pathway; at weaning a transition to saturable absorption occurs indicating a larger
contribution  by  the  transcellular  pathway  during  development,  and  then  the
absorption goes back to the paracellular pathway in adulthood[128].  The molecular
changes associated with these alterations in the intestinal Ca2+ absorption is not well
elucidated. With respect to the transcellular movement, the mRNA expressions of
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Trpv6, Cabp9K, and Pmca1 in the duodenum have been first noted at 14 d and peaked
at 21 days in rodents[129]. Akhter et al[130] have demonstrated at 6 weeks of age that
Cabp9K was highly expressed in the duodenum with a small amount in the jejunum
and cecum,  and at  44  wk it  was  no  longer  detected  in  jejunum and cecum,  but
remained in the duodenum. With regard to paracellular pathway, Holmes et al[131]
have demonstrated in the mice jejunum a decrease in Cldn2 and increases in Cldn12
and Cldn15 with age. These studies highlight that the levels of molecules involved in
the intestinal  Ca2+  absorption are not constant throughout growth.  The potential
modulators of changes in the intestinal Ca2+ absorption during postnatal development
are calcitriol, PRL and milk lactose[132].
Pregnancy
One  of  the  physiological  changes  in  pregnancy  involves  alterations  in
Ca2+metabolism. The adequate growth and development of the fetus is associated
with increased intestinal Ca2+ absorption and renal reabsorption in the mother. In the
first trimester of human pregnancy, the intestinal Ca2+ absorption increases twofold
being  maintained  this  increment  to  term.  This  doubling  in  the  intestinal  Ca2+
absorption seems to be the major maternal adaptation to reach the fetal requirements
for Ca2+either in humans or in rodents[133].  The classical  calciotropic hormones as
calcitriol, PTH and CT seem not to be main responsible for the Ca2+ demand during
pregnancy and lactation[134]. The intestinal Ca2+ absorption has been shown to be VDR-
independent in pregnant VDR knockout mice[135]. Pregnancy up-regulates intestinal
Ca2+ absorption and skeletal mineralization independently of the vitamin D receptor.
It has been suggested that other hormones such as PRL, placental lactogen and GH or
other factors could contribute to the doubling of intestinal Ca2+ absorption in normal
pregnancy[133].
Lactation
After birth,  the maternal  mammalian gland secretes an elevated amount of  Ca2+,
which could reach up to 1000 mg/day of milk Ca2+.  In order to provide an extra
Ca2+for  milk  production  during  lactating  period,  the  osteoclast-mediated  bone
resorption and the intestinal Ca2+ absorption is increased. The hormone responsible
for milk calcium secretion in the stage of lactation remains uncertain, but there is
some  evidence  that  the  lactogenic  hormone  PRL  regulates  that  process.
Charoenphandhu et  al[134]  have  proposed that  PRL stimulates  the  intestinal  Ca2+
absorption in a two-step manner. In step 1, PRL increases the baseline of intestinal
Ca2+ absorption in lactating rats through an increment in the TRPV6 mRNA, whereas
in step 2, the suckling-induced PRL could induce further increased intestinal Ca2+
absorption twofold over the newly increased baseline. High levels of PRL (400-800
mg/mL)  are  required  to  induce  an  acute  enhancement  in  the  intestinal  Ca2+
absorption, which is not attained without suckling[136]. The suckling-increased Ca2+
transport  in  rats  occurs  either  in  the  small  intestine  or  the  large  intestine.  This
increment peaks after 30 min of suckling and lasts for 30-45 min post-suckling[12].
Wongdee et al[97] have demonstrated that PRL upregulated the expression of TRPV6
and PMCA1b  in the duodenum of lactating rats.  In addition,  they have observed
upregulation of FGF-23 protein expression in the duodenum and cecum of the same
animals.  They interpreted that PRL was responsible for the intestinal adaptation
induced by lactation, which was compensated with an increase in FGF-23 to prevent
excessive Ca2+ absorption that might be harmful to lactating rats.
The role of calcitriol in the hyperabsorption of Ca2+ during lactation is not clear.
Kovacs[137] has reported that preterm and term babies absorb Ca2+ through a passive
non saturable process, which is facilitated by the lactose content in the milk. As they
mature, they begin to absorb via a saturable calcitriol-dependent mechanism. This
explains  why vitamin D-deficient  rickets  appears  much later,  six  to  18  mo after
birth[138].  The  phenotype  of  poor  weight  gain  and  low  BMD  in  mice  with  a
nonfunctional VDR is only observed after weaning, which indicates that intestinal
Ca2+ absorption is not calcitriol-dependent while suckling[132]. Recently, Zhang et al[139]
have demonstrated the effects of maternal 25(OH) D3 administration during lactation
on sows and piglets.  The intestinal Ca2+absorption was higher in treated sows as
compared to non-treated sows, which are attributed to increased mRNA expressions
of renal CYP27B1 and duodenal VDR, TRPV6, and CaBP-D9k. The piglets suckling
sows receiving 25(OH) D3  exhibited higher Ca2+  content in tibia and femur; these
effects were associated with higher plasma levels of calcitriol, which increased the
gene expression of proteins involved in the intestinal Ca2+ transport, e.g., VDR and
Cldn-2  in  ileum  and  VDR  and  CB9 k  in  colon.  In  other  words,  25(OH)D3
supplementation during lactation improved bone health of both sow and piglet.
The  temporal  loss  of  bone  mass  during  lactation  is  recovered  promptly  by
mechanisms not  quite  clear.  The  bone health  of  the  mother  could be  slightly  or
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severely compromised leading to fragility fractures in some women. Full recovery of
calcium  content  and  bone  strength  is  not  always  achieved  after  weaning.
Nevertheless,  changes  in  calcium  and  bone  metabolism  during  pregnancy  and
lactation in most women are normal, transient and without deleterious effects in the
long-term[140].
Aging
As a consequence of aging, the intestinal Ca2+ absorption decreases either in humans
or in rodents. In humans, malabsorption of Ca2+ begins approximately at between 65
and 70 years[141]. In postmenopausal women, this deterioration begins earlier, but is
reversible with estrogen therapy[142]. Among the different reasons for this decrease
related to vitamin D metabolism could be mentioned: (1) Decreased renal synthesis of
calcitriol  by  aged  kidney;  (2)  Intestinal  resistance  to  circulating  calcitriol;  (3)
Decreased intestinal VDR; (4) Decreased skin synthesis of vitamin D; and (5) Substrate
deficiency of vitamin D[143]. Song et al[144] have demonstrated that low levels of VDR in
mice heterozygous for the VDR gene KO cause resistance of intestinal Ca2+ absorption
to calcitriol. This resistance appears to be generated by the low translation of CB9k,
which occurs after binding VDR with its ligand. Ramsubeik et al[142] have reported that
beyond the traditional focus on Ca2+ and vitamin D, some other factors also influence
intestinal  Ca2+  absorption  in  post-menopausal  women such  as  dietary  intake  of
kilocalories,  carbohydrates,  and  potassium.  See  Figure  1  for  details  about  the
molecular mechanisms involved in the intestinal Ca2+ absorption and the regulation
by hormones.
OXIDATIVE STRESS AND ANTIOXIDANT AGENTS IN THE
REGULATION OF INTESTINAL CALCIUM ABSORPTION
Reactive oxygen species (ROS) are by-products of normal cellular metabolism and
there are enzymatic and non-enzymatic defense-systems in charge of maintaining a
balance between ROS production and depletion. When this equilibrium fails, it is due
to overproduction of ROS or to a deficiency in protective responses, oxidative stress
arises,  which  can  alter  lipids,  proteins  and  nucleic  acids,  thus  provoking  cell
dysfunction and tissue damage. Gastrointestinal tract is an important source of ROS.
Despite the protective barrier provided by intestinal mucosa and its adequately-
distributed  microbiota,  digestion-endproducts  and  pathogens  can  trigger
inflammatory  response  which  favors  oxidative  stress.  Consequently,  various
gastrointestinal pathologies such as gastroduodenal ulcers, cancer and inflammatory
bowel disease are associated with oxidative stress[145,146].
It has been demonstrated that intestinal Ca2+ absorption is also affected by oxidative
stress. A study carried out in our laboratory demonstrated that DL-buthionine-S, R-
sulfoximine (BSO) reduced intestinal Ca2+ absorption in rachitic chicks treated with
cholecalciferol.  BSO  is  an  aminoacid-analogue  which  inhibits  the  synthesis  of
glutathione (GSH), one of the most important non-enzymatic intestinal antioxidant.
The gut redox status was restored after intraluminal addition of GSH and intestinal
Ca2+  absorption returned to baseline[147].  BSO also reduced the activity of IAP, an
enzyme presumed to  play  a  role  in  Ca2+  absorption,  which  was  affected  by  the
overabundance of ROS triggered by BSO. This reinforces the idea about the potential
inhibitory effect of oxidative stress on the intestinal absorption of the cation[148].
Posterior studies with different pro-oxidant drugs gave more information about the
inhibition of Ca2+ absorption by ROS overproduction. Such is the case of menadione
(MEN),  a  synthetic  precursor  of  vitamin  K  used  in  anti-cancer  therapy.  MEN
metabolism starts by one-electron reduction and originates unstable semiquinone-
radicals which rapidly react with O2. As a result, the semiquinone-radical cycles back
to  MEN  and  .O2-  is  generated,  which  becomes  H2O2  through  spontaneous  or
enzymatic  dismutation [149].  Since  GSH  acts  as  an  electron  donor,  intestinal
administration of  MEN (2.5 μmol /kg b.  w.)  depletes this  antioxidant tripeptide
triggering  oxidative  stress  and  diminishing  the  enzymatic  activity  of  IAP  and
PMCA1b[150]. In the same direction, Areco et al[151] have observed that intraperitoneal
MEN was also able to reduce the expression of PMCA1b, CB28K and CLDN 2 in the
intestinal  mucosa  of  chicks  treated  with  the  quinone.  This  would  contribute  to
explaining the transient reduction in Ca2+ absorption caused by MEN, which appeared
30 minutes after treatment and lasted for less than ten hours. It is worth noting that
this pro-oxidant also provoked apoptosis of enterocytes, thus determining the loss of
approximately 30% of absorptive epithelial cells. The apoptotic process involved both
the  intrinsic  and  extrinsic  pathways.  An  initial  mitochondrial  GSH  depletion
produced a reduction in mitochondrial membrane potential followed by the release of
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Figure 1
Figure 1  Effects of hormones on intestinal Ca2+ absorption. Calcitriol stimulates the transcellular and paracellular absorptive pathways by inducing the expression
of genes and proteins involved in Ca2+ transport and modifying the permeability of tight junctions. Thyroid hormones enhance the genomic actions of calcitriol whereas
glucocorticoids inhibit the transcellular pathway by affecting the expression of Ca2+ transporting proteins. Fibroblast growth factor inhibits the intestinal Ca2+ absorption
antagonizing 1,25(OH)2D3 action. Growth hormone enhances the intestinal Ca2+ absorption through vitamin D dependent and independent mechanisms. PMCA1b:
Plasma membrane Ca2+-ATPase; CB9k: Calbindin 9k; Cav1.3: Ca2+ channel voltage-dependent L type alpha 1D subunit; TRPV5: Transient receptor potential vanilloid
5; TRPV6: Transient receptor potential vanilloid 6; CLDNs 2, 12 and 15: Claudins 2, 12 and 15; NCX1: Na+/Ca2+ exchanger; 1,25(OH)2D3: Calcitriol; FGF-23:
Fibroblast growth factor; GH: Growth hormone; GC: Glucocorticoids; T4: Thyroxine; TJ: Tight junction; VDR: Vitamin D receptor.
cytochrome  c  into  the  cytoplasm  and  DNA  fragmentation  (intrinsic  apoptotic
pathway). Mitochondrial dysfunction induced by MEN affected Krebs-cycle only
partially, since it reduced the activity of malate dehydrogenase in 18% and the one of
α-ketoglutarate dehydrogenase in 30% [152].  Extrinsic apoptotic pathway was also
favored by MEN, which was evidenced by the expression of FAS, FASL and caspase-
3[153]. Interestingly, quercetin, an anti-inflammatory and anti-apoptotic flavonoid with
important protective properties in the intestine[154], could reverse the inhibitory effect
of  MEN.  This  flavonoid  blocked  the  alterations  in  the  mitochondria  membrane
potential  triggered  by  MEN,  thus  blocking  the  apoptotic  route  dependent  on
FAS/FASL-caspase 3. This anti-apoptotic effect, based on the capacity of quercetin to
preserve  GSH  levels,  contributed  to  maintaining  the  absorptive  enterocytes
functioning[153].
The inhibitory effect of MEN on Ca2+ movement can also be prevented or restored
by some protective drugs such as glutamine[155,156],  an anti-inflammatory and anti-
apoptotic drug associated with diverse functions of intestinal mucosa such as growth
and reparation[157,158]. Moine et al[155,156] have observed that glutamine normalized the
content of different molecules involved in both calcium absorption pathways as well
as the levels of GSH and the activity of antioxidant enzymes.
Similarly, a monodosis of 10 mg/kg b. w. of melatonin (MEL), a pineal hormone
also secreted in the gastrointestinal tract, has been shown to restore Ca2+ absorption
previously reduced by MEN. This effect was the result of the normalization of the
activity of antioxidant enzymes superoxide dismutase and catalase and the restoration
of .O2- levels to basal status. MEL also restored the expression of proteins involved in
both Ca2+ absorptive pathways[151]. These protective properties of MEL were reinforced
in various studies that revealed anti-inflammatory effects of MEL in the intestine[159],
helping to maintain epithelial integrity and digestive function[160], and reducing the
risk of cancer[161].
Sodium deoxycholate (NaDOC) is a bile salt that depletes GSH, exerting a similar
effect to the one of MEN. Rivoira et al[162] have demonstrated that high physiological
doses of this salt  inhibit intestinal Ca2+  absorption in a time and dose-dependent
fashion.  NaDOC  mainly  affects  the  transcellular  pathway  since  it  inhibits  the
expression of PMCA1b, CB D28k and NCX1. In addition, this bile-salt generates ROS
and mitochondrial changes which eventually lead to apoptosis[162]. However, there are
some bile  acids that  are able  to  preserve Ca2+  absorption.  Lithocholic  (LCA) is  a
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secondary bile acid that binds to VDR and acts as an endogenous agonist of vitamin
D[163], which has been proposed as a potential antitumoral agent[164]. LCA has proved
to  normalize  the  expression  of  genes  and proteins  involved in  the  transcellular
pathway  of  Ca2+  absorption  affected  by  NaDOC  and  restore  oxidative  stress
parameters such as .O2-  and the levels of protein carbonyl groups.  This acid also
attenuates the increase in the permeability of mitochondrial membrane triggered by
NaDOC, being able to block the apoptosis induced by NaDOC when co-administered
intraluminally  with  this  drug.  As  a  result,  LCA  avoids  the  reduction  in  the
transcellular Ca2+ absorption provoked by NaDOC[165].
There  are  also  pathological  conditions  that  can  favor  oxidative  stress  and
consequently  lead to  a  reduction in  the  intestinal  Ca2+  absorption.  One of  these
conditions is  Type-1 diabetes  mellitus  (T1DM).  Rivoira  et  al[166]  have shown that
diabetic Wistar rats induced by the injection of streptozotocin (STZ), absorbed less
Ca2+ than the control group. This reduction was transitory and reversible by insulin
treatment. Interestingly, STZ-induced diabetes produced an overexpression of the
proteins involved in the transcellular pathway which returned to basal levels after 60
d.  This  initial  increase in the expression of  NCX1,  PMCA1b  and TRPV6 has been
interpreted as a possible compensatory effect to counteract the reduction in Ca2+
absorption, probably associated with an imbalanced redox status.
Ca2+  transport  across  intestinal  epithelium  is  also  impaired  in  experimental
metabolic syndrome. Rodriguez et al[167] have observed that animals with a fructose-
rich diet presented alterations in intestinal redox status, which were evidenced by a
marked increase in .O2-,  lower activity of antioxidant enzymes and a reduction in
GSH. These animals also had nitrosative stress with increased nitric oxide and higher
nitrotyrosine content of proteins.  This global redox disequilibrium determined a
combined alteration of both trans and paracellular pathways of Ca2+ absorption that
might have been aggravated by a pro-inflammatory state with increased IL-6 and NF-
kB. It is noteworthy that a subcutaneous injection of naringin (40 mg/kg b. w. during
4 wk on a daily basis),  an antioxidant flavonoid present in grape fruit  and other
citrics, duplicated GSH level and blocked both inflammation and redox unbalance
triggered by fructose-rich diet, consequently protecting intestinal Ca2+ absorption[167].
These findings go in line with similar antioxidant effects of naringin in ischemia-
reperfusion models[168].  The anti-inflammatory potential  of  naringin on intestinal
mucosa has been confirmed by different studies in ulcerative colitis[169], sepsis-induced
intestinal injury[170], and gastrointestinal tumorigenesis[171]. It has also been found that
naringin contributes to maintaining an equilibrium between the different components
of the microbiota[172],  thus preventing dysbiotic processes that could lead to ROS
overproduction and indirectly affect Ca2+ absorption[173].
Table  1  shows  the  influence  of  prooxidant  conditions  on  the  intestinal  Ca2+
absorption and the reversal/protection by antioxidants.
INTESTINAL CA2+ABSORPTION UNDER PATHOLOGICAL
ALTERATIONS
Inflammatory bowel diseases
Crohn's disease and ulcerative colitis, the main forms of inflammatory bowel disease,
are characterized by chronic inflammation of the intestine that can deteriorate the
intestinal Ca2+ absorption[174]. In patients with Crohn's disease, this alteration may be
due to vitamin D deficiency, magnesium deficiency, excessive use of glucocorticoids
and/or intestinal resection. Vitamin D treatment has been shown to improve the
intestinal Ca2+ absorption in these patients[175].
Celiac disease
Patients with celiac disease (CD) frequently present Ca2+ deficiency, low BMD and
metabolic bone diseases. In children and adolescents with CD, the Ca2+ deficiency may
produce growth alterations and difficulties in peak bone mass achievement[176]. In the
elderly,  Ca2+  deficiency  leads  to  low  BMD  and  increased  fracture  risk[177].  Bone
alterations partially result from impaired intestinal Ca2+ absorption due principally to
the loss of villous cells in the duodenum, where the active Ca2+ transport occurs[178].
Steatorrhea, vitamin D deficit and changes in the mechanisms of Ca2+ absorption are
other factors that contribute to the Ca2+malabsorption[179]. Hipovitaminosis D in CD
patients  is  also  a  consequence  of  its  malabsorption  and  the  intestinal  mucosal
lesion[180], which lead to reduce the plasma calcitriol levels, and therefore, the intestinal
Ca2+ absorption.
Morbid obesity and bariatric surgery
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Table 1  Effects of pro-oxidant conditions on intestinal Ca2+absorption and associated parameters
Pro-oxidant condition
Effects on genes and
proteins involved in
intestinal Ca2+ absorption
Effect on REDOX state Effects of antioxidant/protective molecules Effects on apoptosis




MEN[149-156] Decrease in PMCA1b gene-
protein expression and
activity. Decrease in CB D28k
and CLDN 2 gene-protein
expression
Depletion of GSH content;
Increase in ROS and protein
carbonyls; Enhancement in
SOD and CAT activity




Activation of intrinsic and
extrinsic pathways
NaDOC[162,165] Decrease in PMCA1b mRNA
Inhibition of PMCA1b, CBD28k
and NCX1 protein expression
Depletion of GSH content;
Increase in ROS and activity
of SOD, CAT and GPx;
Increase in iNOS protein
expression and NO• content
QT and UDCA
administration avoided the
inhibition of intestinal Ca2+
absorption caused by NaDOC
Activation of intrinsic and
extrinsic pathway
Diabetes[166] Enhancement in expression of
NCX1, PMCA1b and TRPV6
proteins and CLDN 2 gene
expression
Decrease in GSH content;
Increase in SOD activity and
ROS levels
Insulin treatment restored
redox state and intestinal
Ca2+ absorption
Not evaluated
Metabolic syndrome[167] Decrease in TRPV6, PMCA1b,
CB D9k, CLDN 2, CLDN 12
and VDR protein expression;
Decrease in IAP activity
Enhancement in protein
carbonyls, NO• levels and
nitrotyrosine content in
proteins; Decrease in SOD
and CAT activity
Administration of NAR
prevented the reduction of
intestinal Ca2+ absorption
caused by fructose-rich diet
Not evaluated
BSO: DL-buthionine-S, R-sulfoximine; CAT: Catalase; CB D28k: Calbindin D28k; CB D9k: Calbindin D9k; CLDN 2: Claudin 2; CLDN 12: Claudin 12; GLT:
Glutamine;  GPX:  Glutathione  peroxidase;  GSH:  Glutathione;  AP:  Alkaline  phosphatase;  MEL:  Melatonin;  MEN:  Menadione;  NaDOC:  Sodium
deoxycholate; NAR: Naringin; NCX1: Na+/Ca2+ exchanger; NO•: Nitric oxide; PMCA1b: Plasma membrane Ca
2+ATPase; QT: Quercetin; SOD: Superoxide
dismutase; TRPV6: Transient receptor potential vanilloid type 6; UDCA: Ursodeoxycholic acid; VDR: Vitamin D receptor.
Bariatric surgery (BS) is a valuable option to treat the morbid obesity. However, these
procedures may produce a decrease in the BMD increasing the risk of bone fractures,
particularly when the duodenum is bypassed, as occurs in Roux-en-Y Gastric Bypass
(RYGB). Since the duodenum is the site where the active transport of Ca2+occurs[181],
the RYGB contributes to decreasing not only the intestinal Ca2+ absorption but also the
absorption of other mineral and nutrients. The RYGB prevents the active calcitriol-
mediated Ca2+ transcellular pathway in the duodenum and proximal jejunum, which
resembles in certain extension a proximal intestine-specific Vdr KO animal model[182].
Furthermore, hipovitaminosis D is common in patients exposed to BS, which seems to
be multifactorial, some factors being related to obesity and others related to the type
of the surgical procedure and its consequences[183,184]. Indeed, the vitamin D deficiency
would contribute to inhibiting the intestinal Ca2+ absorption, leading to impaired Ca2+
homeostasis and bone density.  The reduction in the intestinal Ca2+  absorption[185]
produces  secondary  hyperparathyroidism,  and ultimately  triggers  bone  loss[186].
Vitamin D supplementation after RYGB has not always avoided a decrease in BMD,
suggesting that other factors should be involved in the bone loss[132]. In the Sleeve
Gastrectomy, another very common procedure of BS, the contact time between Ca2+
and intestinal cells is shortened and, hence, the intestinal Ca2+ absorption decreases.
Diabetes
The intestinal Ca2+ absorption in diabetes has been poorly addressed. Most studies
have dealt with experimental diabetes provoked by alloxan or STZ. Schneider et al[187]
have demonstrated that  the intestinal  Ca2+  absorption is  decreased in rats  made
diabetic with alloxan, which is due to a decrease in the lumen-to-plasma Ca2+ flux in
the duodenum and ileum. A reduction in intestinal Ca2+ absorption has been reported
to be associated with low circulating levels of calcitriol, decreased VDR number and
CB9k content in diabetic rats[188,189]. In our laboratory we have also observed that the
intestinal Ca2+ absorption decreases by insulin deficiency in rats injected with STZ, a
model of T1DM. However, the effect was relatively rapid and transient leading to a
time dependent adaptation, returning the intestinal Ca2+ absorption to normal values.
The inhibition was accompanied by redox changes that produce oxidative stress,
which may lead to alterations in the duodenum permeability. Both the redox state of
the  intestine  and  the  intestinal  Ca2+  absorption  were  normalized  after  insulin
administration, which was independent of vitamin D status[166]. In a clinical study with
adolescent girls using a dual-stable isotope approach to evaluate Ca2+  absorption,
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Weber  et  al[190]  did  not  find  adverse  effects  of  T1DM  on  gastrointestinal  Ca2+
absorption. Since T1DM is characterized by bone loss, alteration in bone remodeling,
low BMD and increased risk of fractures[191], further investigation should be done in
order  to  clarify  whether  a  reduction in  intestinal  Ca2+  absorption contributes  to
development of bone disease associated to insulin deficiency.
Hypercalciurias
Hypercalciuria  is  very  common  in  patients  with  kidney  stones.  Although  the
molecular  mechanisms  underlying  hypercalciuria  are  not  well  elucidated,  it  is
considered  that  increased  intestinal  Ca2 +  absorption  contributes  to  the
pathogenesis[192]. The idiopatic hypercalciuria is the most common form, but it has a
polygenic trait, which makes more difficult to understand the pathogenesis. In the
Dent disease, a monogenic disorder associated with hypercalciuria, it has also been
found Ca2+ hyperabsorption. Wu et al[193] have demonstrated that the disruption of
PI(4,5)P2  5-phosphatase  activity  by  Dent-causing  mutations  of  OCRL gene  may
explain the increased intestinal Ca2+ absorption. The authors conclude that the TRPV6
activity is enhanced due to the increased transcription of TRPV6 gene provoked by
increased calcitriol[194] and/or release of TRPV6 suppression under Dent conditions.
The hereditary hypophosphatemic rickets with hypercalciuria is a rare autosomal
recessive disorder with a prevalence of 1:250000. The patients carry loss-of-function
mutations in the sodium-phosphate co-transporter NaPi-2c, which cause an increase
in the urinary Pi excretion, hypophosphatemia, bowing, short stature and elevated
calcitriol  levels.  Consequently,  the  intestinal  Ca2+  absorption increases,  the  PTH
dependent  Ca2+-reabsorption  in  the  distal  renal  tubules  decreases,  resulting  in
hypercalcemia, which leads to nephrocalcinosis in half of patients[195].
Turner syndrome
Women with Turner syndrome have an increased risk of osteoporosis mainly due to
inadequately treated primary ovarian insufficiency and intrinsic bone abnormalities.
These patients usually present some comorbid conditions that may further increase
the risk of osteoporosis, such as vitamin D deficiency, CD and inflammatory bowel
disease[196]. All these conditions may be associated with deficient Ca2+ absorption via
different mechanisms such as endocrine deregulation of Ca2+ metabolism or oxidative
stress among others.
Thalassemia
Osteoporosis  and impairment of  Ca2+  homeostasis  are  frequent  complications of
thalassemia.  Studies in thalassemic patients and animal models suggested that a
defective Ca2+ absorption might be a cause of thalassemic bone disorder. The possible
mechanisms  associated  with  intestinal  Ca2+  malabsorption  in  thalassemia  are
alterations in the Ca2+ transporters and hormonal controls of the transcellular and
paracellular intestinal transport systems[108].
CONCLUSION
There has been an important progress in molecular studies related to the effects of
calcitriol on intestinal Ca2+ absorption in rodents and birds. However, information
about  the  role  of  other  hormones  and  dietary  factors  are  scarce.  The  lack  of
information about the molecular alterations in the intestinal Ca2+  absorption that
accompany human pathologies is even greater. Since oxidative stress has shown to
produce a powerful influence on the intestinal Ca2+ absorption and the prevention or
restoration  by  antioxidants  in  experimental  animals  have  proved  to  be  very
successful,  it  would  be  worth  investigating  these  aspects  in  humans  carrying
pathologies associated with altered intestinal Ca2+ absorption.
REFERENCES
1 Vannucci L, Fossi C, Quattrini S, Guasti L, Pampaloni B, Gronchi G, Giusti F, Romagnoli C, Cianferotti
L, Marcucci G, Brandi ML. Calcium Intake in Bone Health: A Focus on Calcium-Rich Mineral Waters.
Nutrients 2018; 10: 1930 [PMID: 30563174 DOI: 10.3390/nu10121930]
2 Diaz de Barboza G, Guizzardi S, Tolosa de Talamoni N. Molecular aspects of intestinal calcium
absorption. World J Gastroenterol 2015; 21: 7142-7154 [PMID: 26109800 DOI:
10.3748/wjg.v21.i23.7142]
3 Liao QS, Du Q, Lou J, Xu JY, Xie R. Roles of Na+/Ca2+ exchanger 1 in digestive system physiology and
pathophysiology. World J Gastroenterol 2019; 25: 287-299 [PMID: 30686898 DOI:
10.3748/wjg.v25.i3.287]
4 Wongdee K, Charoenphandhu N, Litwack G. Vitamin D-Enhanced Duodenal Calcium Transport. Litwack
WJG https://www.wjgnet.com June 28, 2020 Volume 26 Issue 24
Areco VA et al. Ca2+ absorption/molecular and clinical approach
3357
G.  In: Litwack G. Vitamins and hormones. New York: Elsevier, 2015: 407-440
5 Bronner F. Calcium absorption--a paradigm for mineral absorption. J Nutr 1998; 128: 917-920 [PMID:
9567004 DOI: 10.1093/jn/128.5.917]
6 Gloux A, Le Roy N, Brionne A, Bonin E, Juanchich A, Benzoni G, Piketty ML, Prié D, Nys Y, Gautron J,
Narcy A, Duclos MJ. Candidate genes of the transcellular and paracellular calcium absorption pathways in
the small intestine of laying hens. Poult Sci 2019; 98: 6005-6018 [PMID: 31328776 DOI:
10.3382/ps/pez407]
7 Fleet JC, Schoch RD. Molecular mechanisms for regulation of intestinal calcium absorption by vitamin D
and other factors. Crit Rev Clin Lab Sci 2010; 47: 181-195 [PMID: 21182397 DOI:
10.3109/10408363.2010.536429]
8 van der Velde RY, Brouwers JR, Geusens PP, Lems WF, van den Bergh JP. Calcium and vitamin D
supplementation: state of the art for daily practice. Food Nutr Res 2014; 58 [PMID: 25147494 DOI:
10.3402/fnr.v58.21796]
9 Duflos C, Bellaton C, Pansu D, Bronner F. Calcium solubility, intestinal sojourn time and paracellular
permeability codetermine passive calcium absorption in rats. J Nutr 1995; 125: 2348-2355 [PMID:
7666252 DOI: 10.1093/jn/125.9.2348]
10 Wasserman RH. Vitamin D and the dual processes of intestinal calcium absorption. J Nutr 2004; 134:
3137-3139 [PMID: 15514288 DOI: 10.1093/jn/134.11.3137]
11 Charoenphandhu N, Limlomwongse L, Krishnamra N. Prolactin directly stimulates transcellular active
calcium transport in the duodenum of female rats. Can J Physiol Pharmacol 2001; 79: 430-438 [PMID:
11405247]
12 Suntornsaratoon P, Kraidith K, Teerapornpuntakit J, Dorkkam N, Wongdee K, Krishnamra N,
Charoenphandhu N. Pre-suckling calcium supplementation effectively prevents lactation-induced
osteopenia in rats. Am J Physiol Endocrinol Metab 2014; 306: E177-E188 [PMID: 24302005 DOI:
10.1152/ajpendo.00556.2013]
13 Fujita H, Chiba H, Yokozaki H, Sakai N, Sugimoto K, Wada T, Kojima T, Yamashita T, Sawada N.
Differential expression and subcellular localization of claudin-7, -8, -12, -13, and -15 along the mouse
intestine. J Histochem Cytochem 2006; 54: 933-944 [PMID: 16651389 DOI: 10.1369/jhc.6A6944.2006]
14 Inai T, Sengoku A, Guan X, Hirose E, Iida H, Shibata Y. Heterogeneity in expression and subcellular
localization of tight junction proteins, claudin-10 and -15, examined by RT-PCR and immunofluorescence
microscopy. Arch Histol Cytol 2005; 68: 349-360 [PMID: 16505581 DOI: 10.1679/aohc.68.349]
15 Inai T, Kobayashi J, Shibata Y. Claudin-1 contributes to the epithelial barrier function in MDCK cells.
Eur J Cell Biol 1999; 78: 849-855 [PMID: 10669103 DOI: 10.1016/S0171-9335(99)80086-7]
16 Amasheh S, Schmidt T, Mahn M, Florian P, Mankertz J, Tavalali S, Gitter AH, Schulzke JD, Fromm M.
Contribution of claudin-5 to barrier properties in tight junctions of epithelial cells. Cell Tissue Res 2005;
321: 89-96 [PMID: 16158492 DOI: 10.1007/s00441-005-1101-0]
17 van Goor MKC, Hoenderop JGJ, van der Wijst J. TRP channels in calcium homeostasis: from hormonal
control to structure-function relationship of TRPV5 and TRPV6. Biochim Biophys Acta Mol Cell Res
2017; 1864: 883-893 [PMID: 27913205 DOI: 10.1016/j.bbamcr.2016.11.027]
18 Peng JB, Suzuki Y, Gyimesi G, Hediger MA, Kozak J, Putney JJ. TRPV5 and TRPV6 Calcium-Selective
Channels [Internet]. Kozak J, Putney JJ.  In: Kozak J, Putney JJ. Calcium Entry Channels in Non-Excitable
Cells. Boca Raton (FL): CRC Press/Taylor & Francis; 2018: 241-274
19 Brown EM. Extracellular Ca2+ sensing, regulation of parathyroid cell function, and role of Ca2+ and
other ions as extracellular (first) messengers. Physiol Rev 1991; 71: 371-411 [PMID: 2006218 DOI:
10.1152/physrev.1991.71.2.371]
20 Benn BS, Ajibade D, Porta A, Dhawan P, Hediger M, Peng JB, Jiang Y, Oh GT, Jeung EB, Lieben L,
Bouillon R, Carmeliet G, Christakos S. Active intestinal calcium transport in the absence of transient
receptor potential vanilloid type 6 and calbindin-D9k. Endocrinology 2008; 149: 3196-3205 [PMID:
18325990 DOI: 10.1210/en.2007-1655]
21 Kutuzova GD, Sundersingh F, Vaughan J, Tadi BP, Ansay SE, Christakos S, Deluca HF. TRPV6 is not
required for 1alpha,25-dihydroxyvitamin D3-induced intestinal calcium absorption in vivo. Proc Natl Acad
Sci USA 2008; 105: 19655-19659 [PMID: 19073913 DOI: 10.1073/pnas.0810761105]
22 Woudenberg-Vrenken TE, Lameris AL, Weißgerber P, Olausson J, Flockerzi V, Bindels RJ, Freichel M,
Hoenderop JG. Functional TRPV6 channels are crucial for transepithelial Ca2+ absorption. Am J Physiol
Gastrointest Liver Physiol 2012; 303: G879-G885 [PMID: 22878123 DOI: 10.1152/ajpgi.00089.2012]
23 Kellett GL. Alternative perspective on intestinal calcium absorption: proposed complementary actions of
Ca(v)1.3 and TRPV6. Nutr Rev 2011; 69: 347-370 [PMID: 21729089 DOI:
10.1111/j.1753-4887.2011.00395.x]
24 Kojetin DJ, Venters RA, Kordys DR, Thompson RJ, Kumar R, Cavanagh J. Structure, binding interface
and hydrophobic transitions of Ca2+-loaded calbindin-D(28K). Nat Struct Mol Biol 2006; 13: 641-647
[PMID: 16799559 DOI: 10.1038/nsmb1112]
25 Walters JR, Howard A, Lowery LJ, Mawer EB, Legon S. Expression of genes involved in calcium
absorption in human duodenum. Eur J Clin Invest 1999; 29: 214-219 [PMID: 10202378 DOI:
10.1046/j.1365-2362.1999.00439.x]
26 Noble JW, Almalki R, Roe SM, Wagner A, Duman R, Atack JR. The X-ray structure of human calbindin-
D28K: an improved model. Acta Crystallogr D Struct Biol 2018; 74: 1008-1014 [PMID: 30289411 DOI:
10.1107/S2059798318011610]
27 Berggård T, Miron S, Onnerfjord P, Thulin E, Akerfeldt KS, Enghild JJ, Akke M, Linse S. Calbindin
D28k exhibits properties characteristic of a Ca2+ sensor. J Biol Chem 2002; 277: 16662-16672 [PMID:
11872749 DOI: 10.1074/jbc.M200415200]
28 Allbritton NL, Meyer T, Stryer L. Range of messenger action of calcium ion and inositol 1,4,5-
trisphosphate. Science 1992; 258: 1812-1815 [PMID: 1465619 DOI: 10.1126/science.1465619]
29 Merico V, de Barboza GD, Vasco C, Ponce R, Rodriguez V, Garagna S, Tolosa de Talamoni N. A
mitochondrial mechanism is involved in apoptosis of Robertsonian mouse male germ cells. Reproduction
2008; 135: 797-804 [PMID: 18502894 DOI: 10.1530/REP-07-0466]
30 Christakos S, Lieben L, Masuyama R, Carmeliet G. Vitamin D endocrine system and the intestine.
Bonekey Rep 2014; 3: 496 [PMID: 24605213 DOI: 10.1038/bonekey.2013.230]
31 Song Y, Peng X, Porta A, Takanaga H, Peng JB, Hediger MA, Fleet JC, Christakos S. Calcium transporter
1 and epithelial calcium channel messenger ribonucleic acid are differentially regulated by 1,25
dihydroxyvitamin D3 in the intestine and kidney of mice. Endocrinology 2003; 144: 3885-3894 [PMID:
12933662 DOI: 10.1210/en.2003-0314]
WJG https://www.wjgnet.com June 28, 2020 Volume 26 Issue 24
Areco VA et al. Ca2+ absorption/molecular and clinical approach
3358
32 Khuituan P, Teerapornpuntakit J, Wongdee K, Suntornsaratoon P, Konthapakdee N, Sangsaksri J,
Sripong C, Krishnamra N, Charoenphandhu N. Fibroblast growth factor-23 abolishes 1,25-
dihydroxyvitamin D-enhanced duodenal calcium transport in male mice. Am J Physiol Endocrinol Metab
2012; 302: E903-E913 [PMID: 22275752 DOI: 10.1152/ajpendo.00620.2011]
33 Khanal RC, Nemere I. Endocrine regulation of calcium transport in epithelia. Clin Exp Pharmacol
Physiol 2008; 35: 1277-1287 [PMID: 18785975 DOI: 10.1111/j.1440-1681.2008.05053.x]
34 Teerapornpuntakit J, Klanchui A, Karoonuthaisiri N, Wongdee K, Charoenphandhu N. Expression of
transcripts related to intestinal ion and nutrient absorption in pregnant and lactating rats as determined by
custom-designed cDNA microarray. Mol Cell Biochem 2014; 391: 103-116 [PMID: 24519337 DOI:
10.1007/s11010-014-1992-8]
35 Hwang I, Yang H, Kang HS, Ahn C, Hong EJ, An BS, Jeung EB. Alteration of tight junction gene
expression by calcium- and vitamin D-deficient diet in the duodenum of calbindin-null mice. Int J Mol Sci
2013; 14: 22997-23010 [PMID: 24264043 DOI: 10.3390/ijms141122997]
36 Freeman TC, Howard A, Bentsen BS, Legon S, Walters JR. Cellular and regional expression of
transcripts of the plasma membrane calcium pump PMCA1 in rabbit intestine. Am J Physiol 1995; 269:
G126-G131 [PMID: 7631790 DOI: 10.1152/ajpgi.1995.269.1.G126]
37 Ghijsen WE, De Jong MD, Van Os CH. Kinetic properties of Na+/Ca2+ exchange in basolateral plasma
membranes of rat small intestine. Biochim Biophys Acta 1983; 730: 85-94 [PMID: 6403033 DOI:
10.1016/0005-2736(83)90320-6]
38 Centeno VA, Díaz de Barboza GE, Marchionatti AM, Alisio AE, Dallorso ME, Nasif R, Tolosa de
Talamoni NG. Dietary calcium deficiency increases Ca2+ uptake and Ca2+ extrusion mechanisms in chick
enterocytes. Comp Biochem Physiol A Mol Integr Physiol 2004; 139: 133-141 [PMID: 15528161 DOI:
10.1016/j.cbpb.2004.08.002]
39 Nishiyama K, Azuma YT, Kita S, Azuma N, Hayashi S, Nakajima H, Iwamoto T, Takeuchi T. Na/Ca²
exchanger 1/2 double-heterozygote knockout mice display increased nitric oxide component and altered
colonic motility. J Pharmacol Sci 2013; 123: 235-245 [PMID: 24162024 DOI: 10.1254/jphs.13114FP]
40 Kofuji P, Hadley RW, Kieval RS, Lederer WJ, Schulze DH. Expression of the Na-Ca exchanger in diverse
tissues: a study using the cloned human cardiac Na-Ca exchanger. Am J Physiol 1992; 263: C1241-C1249
[PMID: 1476165 DOI: 10.1152/ajpcell.1992.263.6.C1241]
41 Iwamoto T, Kita S, Katsuragi T. Salt-sensitive hypertension, Na+/Ca2+ exchanger, and vascular smooth
muscle. Trends Cardiovasc Med 2005; 15: 273-277 [PMID: 16297763 DOI: 10.1016/j.tcm.2005.08.004]
42 Khananshvili D. Sodium-calcium exchangers (NCX): molecular hallmarks underlying the tissue-specific
and systemic functions. Pflugers Arch 2014; 466: 43-60 [PMID: 24281864 DOI:
10.1007/s00424-013-1405-y]
43 Claassen N, Coetzer H, De Winter R, Haag M, Kruger M. Relationship between duodenal calcium uptake
and Ca2+-Mg2+-ATPase activity. Med Sci Res 1995; 24: 809-811
44 Timmermans JA, Bindels RJ, Van Os CH. Stimulation of plasma membrane Ca2+ pump by calbindin-
D28k and calmodulin is additive in EGTA-free solutions. J Nutr 1995; 125: 1981S-1986S [PMID:
7602380 DOI: 10.1093/jn/125.suppl_7.1981S]
45 Walters JR. Calbindin-D9k stimulates the calcium pump in rat enterocyte basolateral membranes. Am J
Physiol 1989; 256: G124-G128 [PMID: 2536235 DOI: 10.1152/ajpgi.1989.256.1.G124]
46 Tolosa de Talamoni N, Morero R, Cañas F. Vitamin D3 administration increases the membrane fluidity
of intestinal mitochondria. Biochem Int 1989; 19: 701-707 [PMID: 2559727]
47 Alisio A, Cañas F, de Bronia DH, Pereira R, Tolosa de Talamoni N. Effect of vitamin D deficiency on
lipid composition and calcium transport in basolateral membrane vesicles from chick intestine. Biochem
Mol Biol Int 1997; 42: 339-347 [PMID: 9238533 DOI: 10.1080/15216549700202741]
48 Kopic S, Geibel JP. Gastric acid, calcium absorption, and their impact on bone health. Physiol Rev 2013;
93: 189-268 [PMID: 23303909 DOI: 10.1152/physrev.00015.2012]
49 Balesaria S, Sangha S, Walters JR. Human duodenum responses to vitamin D metabolites of TRPV6 and
other genes involved in calcium absorption. Am J Physiol Gastrointest Liver Physiol 2009; 297: G1193-
G1197 [PMID: 19779013 DOI: 10.1152/ajpgi.00237.2009]
50 Haussler MR, Whitfield GK, Kaneko I, Haussler CA, Hsieh D, Hsieh JC, Jurutka PW. Molecular
mechanisms of vitamin D action. Calcif Tissue Int 2013; 92: 77-98 [PMID: 22782502 DOI:
10.1007/s00223-012-9619-0]
51 Meyer T, Hanson PI, Stryer L, Schulman H. Calmodulin trapping by calcium-calmodulin-dependent
protein kinase. Science 1992; 256: 1199-1202 [PMID: 1317063 DOI: 10.1126/science.256.5060.1199]
52 Wasserman RH, Smith CA, Brindak ME, De Talamoni N, Fullmer CS, Penniston JT, Kumar R. Vitamin
D and mineral deficiencies increase the plasma membrane calcium pump of chicken intestine.
Gastroenterology 1992; 102: 886-894 [PMID: 1311274 DOI: 10.1016/0016-5085(92)90174-w]
53 Centeno V, Picotto G, Pérez A, Alisio A, Tolosa de Talamoni N. Intestinal Na(+)/Ca(2+) exchanger
protein and gene expression are regulated by 1,25(OH)(2)D(3) in vitamin D-deficient chicks. Arch
Biochem Biophys 2011; 509: 191-196 [PMID: 21458410 DOI: 10.1016/j.abb.2011.03.011]
54 Christakos S. Recent advances in our understanding of 1,25-dihydroxyvitamin D(3) regulation of
intestinal calcium absorption. Arch Biochem Biophys 2012; 523: 73-76 [PMID: 22230327 DOI:
10.1016/j.abb.2011.12.020]
55 Dhawan P, Veldurthy V, Yehia G, Hsaio C, Porta A, Kim KI, Patel N, Lieben L, Verlinden L, Carmeliet
G, Christakos S. Transgenic Expression of the Vitamin D Receptor Restricted to the Ileum, Cecum, and
Colon of Vitamin D Receptor Knockout Mice Rescues Vitamin D Receptor-Dependent Rickets.
Endocrinology 2017; 158: 3792-3804 [PMID: 28938396 DOI: 10.1210/en.2017-00258]
56 Fahkri H, Zhang B, Fajol A, Hernando N, Elvira B, Mannheim JG, Pichler BJ, Daniel C, Amann K, Hirao
A, Haight J, Mak TW, Lang F, Föller M. Checkpoint kinase Chk2 controls renal Cyp27b1 expression,
calcitriol formation, and calcium-phosphate metabolism. Pflugers Arch 2015; 467: 1871-1880 [PMID:
25319519 DOI: 10.1007/s00424-014-1625-9]
57 Cross HS, Nittke T, Kallay E. Colonic vitamin D metabolism: implications for the pathogenesis of
inflammatory bowel disease and colorectal cancer. Mol Cell Endocrinol 2011; 347: 70-79 [PMID:
21801808 DOI: 10.1016/j.mce.2011.07.022]
58 Ritter CS, Haughey BH, Armbrecht HJ, Brown AJ. Distribution and regulation of the 25-hydroxyvitamin
D3 1α-hydroxylase in human parathyroid glands. J Steroid Biochem Mol Biol 2012; 130: 73-80 [PMID:
22326730 DOI: 10.1016/j.jsbmb.2012.01.010]
59 Nemere I, Garbi N, Hämmerling GJ, Khanal RC. Intestinal cell calcium uptake and the targeted knockout
of the 1,25D3-MARRS (membrane-associated, rapid response steroid-binding) receptor/PDIA3/Erp57. J
WJG https://www.wjgnet.com June 28, 2020 Volume 26 Issue 24
Areco VA et al. Ca2+ absorption/molecular and clinical approach
3359
Biol Chem 2010; 285: 31859-31866 [PMID: 20682787 DOI: 10.1074/jbc.M110.116954]
60 Doroudi M, Schwartz Z, Boyan BD. Membrane-mediated actions of 1,25-dihydroxy vitamin D3: a review
of the roles of phospholipase A2 activating protein and Ca(2+)/calmodulin-dependent protein kinase II. J
Steroid Biochem Mol Biol 2015; 147: 81-84 [PMID: 25448737 DOI: 10.1016/j.jsbmb.2014.11.002]
61 Schwartz Z, Graham EJ, Wang L, Lossdörfer S, Gay I, Johnson-Pais TL, Carnes DL, Sylvia VL, Boyan
BD. Phospholipase A2 activating protein (PLAA) is required for 1alpha,25(OH)2D3 signaling in growth
plate chondrocytes. J Cell Physiol 2005; 203: 54-70 [PMID: 15368540 DOI: 10.1002/jcp.20212]
62 Fujita H, Sugimoto K, Inatomi S, Maeda T, Osanai M, Uchiyama Y, Yamamoto Y, Wada T, Kojima T,
Yokozaki H, Yamashita T, Kato S, Sawada N, Chiba H. Tight junction proteins claudin-2 and -12 are
critical for vitamin D-dependent Ca2+ absorption between enterocytes. Mol Biol Cell 2008; 19: 1912-1921
[PMID: 18287530 DOI: 10.1091/mbc.e07-09-0973]
63 Rexhepaj R, Alesutan I, Gu S, Pelzl L, Eichenmüller M, Pathare G, Föller M, Kuhl D, Lang F. SGK1-
dependent stimulation of intestinal SGLT1 activity by vitamin D. Pflugers Arch 2011; 462: 489-494
[PMID: 21735060 DOI: 10.1007/s00424-011-0987-5]
64 Tudpor K, Teerapornpuntakit J, Jantarajit W, Krishnamra N, Charoenphandhu N. 1,25-dihydroxyvitamin
D(3) rapidly stimulates the solvent drag-induced paracellular calcium transport in the duodenum of female
rats. J Physiol Sci 2008; 58: 297-307 [PMID: 18838052 DOI: 10.2170/physiolsci.RP002308]
65 Kutuzova GD, Deluca HF. Gene expression profiles in rat intestine identify pathways for 1,25-
dihydroxyvitamin D(3) stimulated calcium absorption and clarify its immunomodulatory properties. Arch
Biochem Biophys 2004; 432: 152-166 [PMID: 15542054 DOI: 10.1016/j.abb.2004.09.004]
66 Zierold C, Mings JA, DeLuca HF. Regulation of 25-hydroxyvitamin D3-24-hydroxylase mRNA by 1,25-
dihydroxyvitamin D3 and parathyroid hormone. J Cell Biochem 2003; 88: 234-237 [PMID: 12520520
DOI: 10.1002/jcb.10341]
67 Pantazi H, Papapetrou PD. Changes in parameters of bone and mineral metabolism during therapy for
hyperthyroidism. J Clin Endocrinol Metab 2000; 85: 1099-1106 [PMID: 10720046 DOI:
10.1210/jcem.85.3.6457]
68 Karunakaran P, Maharajan C, Chockalingam R, Asokumar P, Koramadai Karuppusamy K, Sadasivam
V. The effect of total thyroidectomy on the recovery of bone mineral density in subjects with
hyperthyroidism. Surgery 2019; 165: 80-84 [PMID: 30415871 DOI: 10.1016/j.surg.2018.05.082]
69 Cross HS, Debiec H, Peterlik M. Thyroid hormone enhances the genomic action of calcitriol in the small
intestine. Prog Clin Biol Res 1990; 332: 163-180 [PMID: 2330382]
70 Cross HS, Peterlik M. Cooperative effect of thyroid hormones and vitamin D on intestinal calcium and
phosphate transport. Prog Clin Biol Res 1988; 252: 331-336 [PMID: 3347623]
71 Kumar V, Prasad R. Thyroid hormones stimulate calcium transport systems in rat intestine. Biochim
Biophys Acta 2003; 1639: 185-194 [PMID: 14636950 DOI: 10.1016/j.bbadis.2003.09.006]
72 Shulman DI. Gastrointestinal effects of growth hormone. Endocrine 2000; 12: 147-152 [PMID: 10905374
DOI: 10.1385/ENDO:12:2:147]
73 Denson LA, Kim MO, Bezold R, Carey R, Osuntokun B, Nylund C, Willson T, Bonkowski E, Li D,
Ballard E, Collins M, Moyer MS, Klein DJ. A randomized controlled trial of growth hormone in active
pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2010; 51: 130-139 [PMID: 20453679 DOI:
10.1097/MPG.0b013e3181c992d6]
74 Slonim AE, Bulone L, Damore MB, Goldberg T, Wingertzahn MA, McKinley MJ. A preliminary study of
growth hormone therapy for Crohn's disease. N Engl J Med 2000; 342: 1633-1637 [PMID: 10833209 DOI:
10.1056/NEJM200006013422203]
75 Byrne TA, Wilmore DW, Iyer K, Dibaise J, Clancy K, Robinson MK, Chang P, Gertner JM, Lautz D.
Growth hormone, glutamine, and an optimal diet reduces parenteral nutrition in patients with short bowel
syndrome: a prospective, randomized, placebo-controlled, double-blind clinical trial. Ann Surg 2005; 242:
655-661 [PMID: 16244538 DOI: 10.1097/01.sla.0000186479.53295.14]
76 Seguy D, Vahedi K, Kapel N, Souberbielle JC, Messing B. Low-dose growth hormone in adult home
parenteral nutrition-dependent short bowel syndrome patients: a positive study. Gastroenterology 2003;
124: 293-302 [PMID: 12557135 DOI: 10.1053/gast.2003.50057]
77 Zoidis E, Gosteli-Peter M, Ghirlanda-Keller C, Meinel L, Zapf J, Schmid C. IGF-I and GH stimulate Phex
mRNA expression in lungs and bones and 1,25-dihydroxyvitamin D(3) production in hypophysectomized
rats. Eur J Endocrinol 2002; 146: 97-105 [PMID: 11751074 DOI: 10.1530/eje.0.1460097]
78 Chen C, Noland KA, Kalu DN. Modulation of intestinal vitamin D receptor by ovariectomy, estrogen and
growth hormone. Mech Ageing Dev 1997; 99: 109-122 [PMID: 9483486 DOI:
10.1016/s0047-6374(97)00094-8]
79 Fleet JC. The role of vitamin D in the endocrinology controlling calcium homeostasis. Mol Cell
Endocrinol 2017; 453: 36-45 [PMID: 28400273 DOI: 10.1016/j.mce.2017.04.008]
80 Fleet JC, Bruns ME, Hock JM, Wood RJ. Growth hormone and parathyroid hormone stimulate intestinal
calcium absorption in aged female rats. Endocrinology 1994; 134: 1755-1760 [PMID: 8137740 DOI:
10.1210/endo.134.4.8137740]
81 Fatayerji D, Mawer EB, Eastell R. The role of insulin-like growth factor I in age-related changes in
calcium homeostasis in men. J Clin Endocrinol Metab 2000; 85: 4657-4662 [PMID: 11134124 DOI:
10.1210/jcem.85.12.7031]
82 Heaney RP, Recker RR, Saville PD. Menopausal changes in calcium balance performance. J Lab Clin
Med 1978; 92: 953-963 [PMID: 739173]
83 Riggs BL, Khosla S, Melton LJ. Sex steroids and the construction and conservation of the adult skeleton.
Endocr Rev 2002; 23: 279-302 [PMID: 12050121 DOI: 10.1210/edrv.23.3.0465]
84 Gallagher JC, Riggs BL, DeLuca HF. Effect of estrogen on calcium absorption and serum vitamin D
metabolites in postmenopausal osteoporosis. J Clin Endocrinol Metab 1980; 51: 1359-1364 [PMID:
6255005 DOI: 10.1210/jcem-51-6-1359]
85 Pavlovitch H, Clemens TL, Laouari D, O'Riordan JL, Balsan S. Lack of effect on ovariectomy on the
metabolism of vitamin D and intestinal calcium-binding protein in female rats. J Endocrinol 1980; 86:
419-424 [PMID: 7430901 DOI: 10.1677/joe.0.0860419]
86 O'Loughlin PD, Morris HA. Oestrogen deficiency impairs intestinal calcium absorption in the rat. J
Physiol 1998; 511: 313-322 [PMID: 9679184 DOI: 10.1111/j.1469-7793.1998.313bi.x]
87 van Abel M, Hoenderop JG, van der Kemp AW, van Leeuwen JP, Bindels RJ. Regulation of the epithelial
Ca2+ channels in small intestine as studied by quantitative mRNA detection. Am J Physiol Gastrointest
Liver Physiol 2003; 285: G78-G85 [PMID: 12620887 DOI: 10.1152/ajpgi.00036.2003]
88 Gennari C, Agnusdei D, Nardi P, Civitelli R. Estrogen preserves a normal intestinal responsiveness to
WJG https://www.wjgnet.com June 28, 2020 Volume 26 Issue 24
Areco VA et al. Ca2+ absorption/molecular and clinical approach
3360
1,25-dihydroxyvitamin D3 in oophorectomized women. J Clin Endocrinol Metab 1990; 71: 1288-1293
[PMID: 2229286 DOI: 10.1210/jcem-71-5-1288]
89 Arjmandi BH, Hollis BW, Kalu DN. In vivo effect of 17 beta-estradiol on intestinal calcium absorption in
rats. Bone Miner 1994; 26: 181-189 [PMID: 7994189 DOI: 10.1016/s0169-6009(08)80062-1]
90 Liel Y, Shany S, Smirnoff P, Schwartz B. Estrogen increases 1,25-dihydroxyvitamin D receptors
expression and bioresponse in the rat duodenal mucosa. Endocrinology 1999; 140: 280-285 [PMID:
9886836 DOI: 10.1210/endo.140.1.6408]
91 Colin EM, Van Den Bemd GJ, Van Aken M, Christakos S, De Jonge HR, Deluca HF, Prahl JM,
Birkenhäger JC, Buurman CJ, Pols HA, Van Leeuwen JP. Evidence for involvement of 17beta-estradiol in
intestinal calcium absorption independent of 1,25-dihydroxyvitamin D3 level in the Rat. J Bone Miner Res
1999; 14: 57-64 [PMID: 9893066 DOI: 10.1359/jbmr.1999.14.1.57]
92 Cotter AA, Cashman KD. Effect of 17beta-oestradiol on transepithelial calcium transport in human
intestinal-like Caco-2 cells and its interactions with 1,25-dihydroxycholecalciferol and 9-cis retinoic acid.
Eur J Nutr 2006; 45: 234-241 [PMID: 16491319 DOI: 10.1007/s00394-006-0590-2]
93 Campbell-Thompson M, Lynch IJ, Bhardwaj B. Expression of estrogen receptor (ER) subtypes and
ERbeta isoforms in colon cancer. Cancer Res 2001; 61: 632-640 [PMID: 11212261]
94 Nie X, Jin H, Wen G, Xu J, An J, Liu X, Xie R, Tuo B. Estrogen Regulates Duodenal Calcium Absorption
Through Differential Role of Estrogen Receptor on Calcium Transport Proteins. Dig Dis Sci 2020; Online
ahead of print [PMID: 31974908 DOI: 10.1007/s10620-020-06076-x]
95 Ajibade DV, Dhawan P, Fechner AJ, Meyer MB, Pike JW, Christakos S. Evidence for a role of prolactin
in calcium homeostasis: regulation of intestinal transient receptor potential vanilloid type 6, intestinal
calcium absorption, and the 25-hydroxyvitamin D(3) 1alpha hydroxylase gene by prolactin. Endocrinology
2010; 151: 2974-2984 [PMID: 20463051 DOI: 10.1210/en.2010-0033]
96 Pahuja DN, DeLuca HF. Stimulation of intestinal calcium transport and bone calcium mobilization by
prolactin in vitamin D-deficient rats. Science 1981; 214: 1038-1039 [PMID: 7302575 DOI: 10.1126/sci-
ence.7302575]
97 Wongdee K, Teerapornpuntakit J, Sripong C, Longkunan A, Chankamngoen W, Keadsai C, Kraidith K,
Krishnamra N, Charoenphandhu N. Intestinal mucosal changes and upregulated calcium transporter and
FGF-23 expression during lactation: Contribution of lactogenic hormone prolactin. Arch Biochem Biophys
2016; 590: 109-117 [PMID: 26657069 DOI: 10.1016/j.abb.2015.11.038]
98 Charoenphandhu N, Nakkrasae LI, Kraidith K, Teerapornpuntakit J, Thongchote K, Thongon N,
Krishnamra N. Two-step stimulation of intestinal Ca(2+) absorption during lactation by long-term
prolactin exposure and suckling-induced prolactin surge. Am J Physiol Endocrinol Metab 2009; 297:
E609-E619 [PMID: 19567804 DOI: 10.1152/ajpendo.00347.2009]
99 Marcucci G, Masi L, Ferrarì S, Haffner D, Javaid MK, Kamenický P, Reginster JY, Rizzoli R, Brandi
ML. Phosphate wasting disorders in adults. Osteoporos Int 2018; 29: 2369-2387 [PMID: 30014155 DOI:
10.1007/s00198-018-4618-2]
100 Khuituan P, Wongdee K, Jantarajit W, Suntornsaratoon P, Krishnamra N, Charoenphandhu N. Fibroblast
growth factor-23 negates 1,25(OH)2D3-induced intestinal calcium transport by reducing the transcellular
and paracellular calcium fluxes. Arch Biochem Biophys 2013; 536: 46-52 [PMID: 23747333 DOI:
10.1016/j.abb.2013.05.009]
101 Rodrat M, Wongdee K, Panupinthu N, Thongbunchoo J, Teerapornpuntakit J, Krishnamra N,
Charoenphandhu N. Prolonged exposure to 1,25(OH)2D3 and high ionized calcium induces FGF-23
production in intestinal epithelium-like Caco-2 monolayer: A local negative feedback for preventing
excessive calcium transport. Arch Biochem Biophys 2018; 640: 10-16 [PMID: 29317227 DOI:
10.1016/j.abb.2017.12.022]
102 Sutter SA, Stein EM. The Skeletal Effects of Inhaled Glucocorticoids. Curr Osteoporos Rep 2016; 14:
106-113 [PMID: 27091558 DOI: 10.1007/s11914-016-0308-1]
103 Van Cromphaut SJ, Stockmans I, Torrekens S, Van Herck E, Carmeliet G, Bouillon R. Duodenal
calcium absorption in dexamethasone-treated mice: functional and molecular aspects. Arch Biochem
Biophys 2007; 460: 300-305 [PMID: 17224125 DOI: 10.1016/j.abb.2006.11.027]
104 Kim MH, Lee GS, Jung EM, Choi KC, Jeung EB. The negative effect of dexamethasone on calcium-
processing gene expressions is associated with a glucocorticoid-induced calcium-absorbing disorder. Life
Sci 2009; 85: 146-152 [PMID: 19490920 DOI: 10.1016/j.lfs.2009.05.013]
105 Zhang Y, Shao J, Wang Z, Yang T, Liu S, Liu Y, Fan X, Ye W. Aqueous extract of pomegranate seed
attenuates glucocorticoid-induced bone loss and hypercalciuria in mice: A comparative study with
alendronate. Int J Mol Med 2016; 38: 491-498 [PMID: 27278225 DOI: 10.3892/ijmm.2016.2622]
106 Swaminathan R, Ker J, Care D. Calcitonin and intestinal calcium absorption. J Endocrinol 1974; 61: 83-
94 [PMID: 4829164 DOI: 10.1677/joe.0.0610083]
107 Wongsurawat N, Armbrecht HJ. Calcitonin stimulates 1,25-dihydroxyvitamin D production in diabetic rat
kidney. Metabolism 1991; 40: 22-25 [PMID: 1984564 DOI: 10.1016/0026-0495(91)90186-z]
108 Lertsuwan K, Wongdee K, Teerapornpuntakit J, Charoenphandhu N. Intestinal calcium transport and its
regulation in thalassemia: interaction between calcium and iron metabolism. J Physiol Sci 2018; 68: 221-
232 [PMID: 29484538 DOI: 10.1007/s12576-018-0600-1]
109 Centeno V, de Barboza GD, Marchionatti A, Rodríguez V, Tolosa de Talamoni N. Molecular mechanisms
triggered by low-calcium diets. Nutr Res Rev 2009; 22: 163-174 [PMID: 19835652 DOI:
10.1017/S0954422409990126]
110 Anderson JJ, Kruszka B, Delaney JA, He K, Burke GL, Alonso A, Bild DE, Budoff M, Michos ED.
Calcium Intake From Diet and Supplements and the Risk of Coronary Artery Calcification and its
Progression Among Older Adults: 10-Year Follow-up of the Multi-Ethnic Study of Atherosclerosis
(MESA). J Am Heart Assoc 2016; 5 [PMID: 27729333 DOI: 10.1161/JAHA.116.003815]
111 Rule AD, Roger VL, Melton LJ, Bergstralh EJ, Li X, Peyser PA, Krambeck AE, Lieske JC. Kidney stones
associate with increased risk for myocardial infarction. J Am Soc Nephrol 2010; 21: 1641-1644 [PMID:
20616170 DOI: 10.1681/ASN.2010030253]
112 Wongdee K, Rodrat M, Teerapornpuntakit J, Krishnamra N, Charoenphandhu N. Factors inhibiting
intestinal calcium absorption: hormones and luminal factors that prevent excessive calcium uptake. J
Physiol Sci 2019; 69: 683-696 [PMID: 31222614 DOI: 10.1007/s12576-019-00688-3]
113 Christakos S, Dhawan P, Liu Y, Peng X, Porta A. New insights into the mechanisms of vitamin D action.
J Cell Biochem 2003; 88: 695-705 [PMID: 12577303 DOI: 10.1002/jcb.10423]
114 Brown AJ, Krits I, Armbrecht HJ. Effect of age, vitamin D, and calcium on the regulation of rat intestinal
epithelial calcium channels. Arch Biochem Biophys 2005; 437: 51-58 [PMID: 15820216 DOI:
WJG https://www.wjgnet.com June 28, 2020 Volume 26 Issue 24
Areco VA et al. Ca2+ absorption/molecular and clinical approach
3361
10.1016/j.abb.2005.02.007]
115 Brun LR, Brance ML, Rigalli A. Luminal calcium concentration controls intestinal calcium absorption by
modification of intestinal alkaline phosphatase activity. Br J Nutr 2012; 108: 229-233 [PMID: 22018098
DOI: 10.1017/S0007114511005617]
116 Bangkok T. Human Vitamin and Mineral Requirements.  Rome, Italy: 2001. Available from:
http://www.fao.org/3/a-y2809e.pdf
117 Favus MJ, Goltzman D. Regulation of Calcium and Magnesium.  In: Primer on the Metabolic Bone
Diseases and Disorders of Mineral Metabolism. Ames: John Wiley & Sons, Inc.; 2013: 171-179
118 Brun LR, Brance ML, Lombarte M, Lupo M, Di Loreto VE, Rigalli A. Regulation of intestinal calcium
absorption by luminal calcium content: role of intestinal alkaline phosphatase. Mol Nutr Food Res 2014;
58: 1546-1551 [PMID: 24753180 DOI: 10.1002/mnfr.201300686]
119 Brun LR, Lombarte M, Roma S, Perez F, Millán JL, Rigalli A. Increased calcium uptake and improved
trabecular bone properties in intestinal alkaline phosphatase knockout mice. J Bone Miner Metab 2018; 36:
661-667 [PMID: 29234952 DOI: 10.1007/s00774-017-0887-7]
120 Cheng SX, Okuda M, Hall AE, Geibel JP, Hebert SC. Expression of calcium-sensing receptor in rat
colonic epithelium: evidence for modulation of fluid secretion. Am J Physiol Gastrointest Liver Physiol
2002; 283: G240-G250 [PMID: 12065312 DOI: 10.1152/ajpgi.00500.2001]
121 Rutten MJ, Bacon KD, Marlink KL, Stoney M, Meichsner CL, Lee FP, Hobson SA, Rodland KD,
Sheppard BC, Trunkey DD, Deveney KE, Deveney CW. Identification of a functional Ca2+-sensing
receptor in normal human gastric mucous epithelial cells. Am J Physiol 1999; 277: G662-G670 [PMID:
10484392 DOI: 10.1152/ajpgi.1999.277.3.G662]
122 Xie R, Dong X, Wong C, Vallon V, Tang B, Sun J, Yang S, Dong H. Molecular mechanisms of calcium-
sensing receptor-mediated calcium signaling in the modulation of epithelial ion transport and bicarbonate
secretion. J Biol Chem 2014; 289: 34642-34653 [PMID: 25331955 DOI: 10.1074/jbc.M114.592774]
123 Cheng SX, Lightfoot YL, Yang T, Zadeh M, Tang L, Sahay B, Wang GP, Owen JL, Mohamadzadeh M.
Epithelial CaSR deficiency alters intestinal integrity and promotes proinflammatory immune responses.
FEBS Lett 2014; 588: 4158-4166 [PMID: 24842610 DOI: 10.1016/j.febslet.2014.05.007]
124 Owen JL, Cheng SX, Ge Y, Sahay B, Mohamadzadeh M. The role of the calcium-sensing receptor in
gastrointestinal inflammation. Semin Cell Dev Biol 2016; 49: 44-51 [PMID: 26709005 DOI:
10.1016/j.semcdb.2015.10.040]
125 Iamartino L, Elajnaf T, Kallay E, Schepelmann M. Calcium-sensing receptor in colorectal inflammation
and cancer: Current insights and future perspectives. World J Gastroenterol 2018; 24: 4119-4131 [PMID:
30271078 DOI: 10.3748/wjg.v24.i36.4119]
126 Hillman LS, Johnson LS, Lee DZ, Vieira NE, Yergey AL. Measurement of true absorption, endogenous
fecal excretion, urinary excretion, and retention of calcium in term infants by using a dual-tracer, stable-
isotope method. J Pediatr 1993; 123: 444-456 [PMID: 8355125 DOI: 10.1016/S0022-3476(05)81755-X]
127 Alevizaki CC, Ikkos DG, Singhelakis P. Progressive decrease of true intestinal calcium absorption with
age in normal man. J Nucl Med 1973; 14: 760-762 [PMID: 4743584]
128 Ghishan FK, Parker P, Nichols S, Hoyumpa A. Kinetics of intestinal calcium transport during maturation
in rats. Pediatr Res 1984; 18: 235-239 [PMID: 6728555 DOI: 10.1203/00006450-198403000-00003]
129 Lee GS, Lee KY, Choi KC, Ryu YH, Paik SG, Oh GT, Jeung EB. Phenotype of a calbindin-D9k gene
knockout is compensated for by the induction of other calcium transporter genes in a mouse model. J Bone
Miner Res 2007; 22: 1968-1978 [PMID: 17696760 DOI: 10.1359/jbmr.070801]
130 Akhter S, Kutuzova GD, Christakos S, DeLuca HF. Calbindin D9k is not required for 1,25-
dihydroxyvitamin D3-mediated Ca2+ absorption in small intestine. Arch Biochem Biophys 2007; 460: 227-
232 [PMID: 17224126 DOI: 10.1016/j.abb.2006.12.005]
131 Holmes JL, Van Itallie CM, Rasmussen JE, Anderson JM. Claudin profiling in the mouse during postnatal
intestinal development and along the gastrointestinal tract reveals complex expression patterns. Gene Expr
Patterns 2006; 6: 581-588 [PMID: 16458081 DOI: 10.1016/j.modgep.2005.12.001]
132 Beggs MR, Alexander RT. Intestinal absorption and renal reabsorption of calcium throughout postnatal
development. Exp Biol Med (Maywood) 2017; 242: 840-849 [PMID: 28346014 DOI:
10.1177/1535370217699536]
133 Kovacs CS. Maternal Mineral and Bone Metabolism During Pregnancy, Lactation, and Post-Weaning
Recovery. Physiol Rev 2016; 96: 449-547 [PMID: 26887676 DOI: 10.1152/physrev.00027.2015]
134 Charoenphandhu N, Wongdee K, Krishnamra N. Is prolactin the cardinal calciotropic maternal hormone?
Trends Endocrinol Metab 2010; 21: 395-401 [PMID: 20304671 DOI: 10.1016/j.tem.2010.02.002]
135 Fudge NJ, Kovacs CS. Pregnancy up-regulates intestinal calcium absorption and skeletal mineralization
independently of the vitamin D receptor. Endocrinology 2010; 151: 886-895 [PMID: 20051486 DOI:
10.1210/en.2009-1010]
136 Jantarajit W, Thongon N, Pandaranandaka J, Teerapornpuntakit J, Krishnamra N, Charoenphandhu N.
Prolactin-stimulated transepithelial calcium transport in duodenum and Caco-2 monolayer are mediated by
the phosphoinositide 3-kinase pathway. Am J Physiol Endocrinol Metab 2007; 293: E372-E384 [PMID:
17488805 DOI: 10.1152/ajpendo.00142.2007]
137 Kovacs CS. The role of vitamin D in pregnancy and lactation: insights from animal models and clinical
studies. Annu Rev Nutr 2012; 32: 97-123 [PMID: 22483092 DOI: 10.1146/annurev-nutr-071811-150742]
138 Kovacs C. Fetal mineral homeostasis [Internet].  In: Glorieux F, Pettifor J, Juppner H. Pediatric Bone:
Biology and Diseases. Endotext: Comprehensive free online endocrinoloy book. San Diego, CA:
Elsevier/Academic; 2011: 247-275
139 Zhang L, Hu J, Li M, Shang Q, Liu S, Piao X. Maternal 25-hydroxycholecalciferol during lactation
improves intestinal calcium absorption and bone properties in sow-suckling piglet pairs. J Bone Miner
Metab 2019; 37: 1083-1094 [PMID: 31290004 DOI: 10.1007/s00774-019-01020-0]
140 Kovacs CS, Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, Hershman JM,
Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Perreault L, Purnell J, Rebar
R, Singer F, Trence DL, Vinik A, Wilson DP.   Calcium and Phosphate Metabolism and Related Disorders
During Pregnancy and Lactation 2000 [PMID: 25905396]
141 Bullamore JR, Wilkinson R, Gallagher JC, Nordin BE, Marshall DH. Effect of age on calcium absorption.
Lancet 1970; 2: 535-537 [PMID: 4195202 DOI: 10.1016/s0140-6736(70)91344-9]
142 Ramsubeik K, Keuler NS, Davis LA, Hansen KE. Factors associated with calcium absorption in
postmenopausal women: a post hoc analysis of dual-isotope studies. J Acad Nutr Diet 2014; 114: 761-767
[PMID: 24209888 DOI: 10.1016/j.jand.2013.07.041]
143 Gallagher JC. Vitamin D and aging. Endocrinol Metab Clin North Am 2013; 42: 319-332 [PMID:
WJG https://www.wjgnet.com June 28, 2020 Volume 26 Issue 24
Areco VA et al. Ca2+ absorption/molecular and clinical approach
3362
23702404 DOI: 10.1016/j.ecl.2013.02.004]
144 Song Y, Fleet JC. Intestinal resistance to 1,25 dihydroxyvitamin D in mice heterozygous for the vitamin D
receptor knockout allele. Endocrinology 2007; 148: 1396-1402 [PMID: 17110426 DOI:
10.1210/en.2006-1109]
145 Bhattacharyya A, Chattopadhyay R, Mitra S, Crowe SE. Oxidative stress: an essential factor in the
pathogenesis of gastrointestinal mucosal diseases. Physiol Rev 2014; 94: 329-354 [PMID: 24692350 DOI:
10.1152/physrev.00040.2012]
146 Clark A, Mach N. The Crosstalk between the Gut Microbiota and Mitochondria during Exercise. Front
Physiol 2017; 8: 319 [PMID: 28579962 DOI: 10.3389/fphys.2017.00319]
147 Tolosa de Talamoni N, Marchionatti A, Baudino V, Alisio A. Glutathione plays a role in the chick
intestinal calcium absorption. Comp Biochem Physiol A Physiol 1996; 115: 127-132 [PMID: 8916550
DOI: 10.1016/0300-9629(96)00023-0]
148 Marchionatti A, Alisio A, Díaz de Barboza G, Baudino V, Tolosa de Talamoni N. DL-Buthionine-S,R-
sulfoximine affects intestinal alkaline phosphatase activity. Comp Biochem Physiol C Toxicol Pharmacol
2001; 129: 85-91 [PMID: 11423381]
149 Diaz de Barboza G, Guizzardi S, Moine L, Tolosa de Talamoni N. Oxidative stress, antioxidants and
intestinal calcium absorption. World J Gastroenterol 2017; 23: 2841-2853 [PMID: 28522903 DOI:
10.3748/wjg.v23.i16.2841]
150 Marchionatti AM, Díaz de Barboza GE, Centeno VA, Alisio AE, Tolosa de Talamoni NG. Effects of a
single dose of menadione on the intestinal calcium absorption and associated variables. J Nutr Biochem
2003; 14: 466-472 [PMID: 12948877 DOI: 10.1016/S0955-2863(03)00078-0]
151 Areco V, Rodriguez V, Marchionatti A, Carpentieri A, Tolosa de Talamoni N. Melatonin not only restores
but also prevents the inhibition of the intestinal Ca(2+) absorption caused by glutathione depleting drugs.
Comp Biochem Physiol A Mol Integr Physiol 2016; 197: 16-22 [PMID: 26970583 DOI:
10.1016/j.cbpa.2016.03.005]
152 Marchionatti AM, Perez AV, Diaz de Barboza GE, Pereira BM, Tolosa de Talamoni NG. Mitochondrial
dysfunction is responsible for the intestinal calcium absorption inhibition induced by menadione. Biochim
Biophys Acta 2008; 1780: 101-107 [PMID: 18053815 DOI: 10.1016/j.bbagen.2007.10.020]
153 Marchionatti AM, Pacciaroni A, Tolosa de Talamoni NG. Effects of quercetin and menadione on
intestinal calcium absorption and the underlying mechanisms. Comp Biochem Physiol A Mol Integr
Physiol 2013; 164: 215-220 [PMID: 23000882 DOI: 10.1016/j.cbpa.2012.09.007]
154 Hong Z, Piao M. Effect of Quercetin Monoglycosides on Oxidative Stress and Gut Microbiota Diversity in
Mice with Dextran Sodium Sulphate-Induced Colitis. Biomed Res Int 2018; 2018: 8343052 [PMID:
30539022 DOI: 10.1155/2018/8343052]
155 Moine L, Díaz de Barboza G, Pérez A, Benedetto M, Tolosa de Talamoni N. Glutamine protects intestinal
calcium absorption against oxidative stress and apoptosis. Comp Biochem Physiol A Mol Integr Physiol
2017; 212: 64-71 [PMID: 28732794 DOI: 10.1016/j.cbpa.2017.07.006]
156 Moine L, Pérez A, Maldonado C, Tolosa de Talamoni N, Díaz de Barboza G. Glutamine protects both
transcellular and paracellular pathways of chick intestinal calcium absorption under oxidant conditions.
Comp Biochem Physiol A Mol Integr Physiol 2019; 238: 110553 [PMID: 31437565 DOI:
10.1016/j.cbpa.2019.110553]
157 Chen J, Zhang S, Wu J, Wu S, Xu G, Wei D. Essential Role of Nonessential Amino Acid Glutamine in
Atherosclerotic Cardiovascular Disease. DNA Cell Biol 2020; 39: 8-15 [PMID: 31825254 DOI:
10.1089/dna.2019.5034]
158 Kim MH, Kim H. The Roles of Glutamine in the Intestine and Its Implication in Intestinal Diseases. Int J
Mol Sci 2017; 18 [PMID: 28498331 DOI: 10.3390/ijms18051051]
159 Carrascal L, Nunez-Abades P, Ayala A, Cano M. Role of Melatonin in the Inflammatory Process and its
Therapeutic Potential. Curr Pharm Des 2018; 24: 1563-1588 [PMID: 29701146 DOI:
10.2174/1381612824666180426112832]
160 Li RX, Li J, Zhang SY, Mi YL, Zhang CQ. Attenuating effect of melatonin on lipopolysaccharide-induced
chicken small intestine inflammation. Poult Sci 2018; 97: 2295-2302 [PMID: 29596657 DOI:
10.3382/ps/pey084]
161 Shafabakhsh R, Reiter RJ, Davoodabadi A, Asemi Z. Melatonin as a potential inhibitor of colorectal
cancer: Molecular mechanisms. J Cell Biochem 2019; 120: 12216-12223 [PMID: 31087705 DOI:
10.1002/jcb.28833]
162 Rivoira MA, Marchionatti AM, Centeno VA, Díaz de Barboza GE, Peralta López ME, Tolosa de
Talamoni NG. Sodium deoxycholate inhibits chick duodenal calcium absorption through oxidative stress
and apoptosis. Comp Biochem Physiol A Mol Integr Physiol 2012; 162: 397-405 [PMID: 22561666 DOI:
10.1016/j.cbpa.2012.04.016]
163 Makishima M, Lu TT, Xie W, Whitfield GK, Domoto H, Evans RM, Haussler MR, Mangelsdorf DJ.
Vitamin D receptor as an intestinal bile acid sensor. Science 2002; 296: 1313-1316 [PMID: 12016314
DOI: 10.1126/science.1070477]
164 Zhao MX, Cai ZC, Zhu BJ, Zhang ZQ. The Apoptosis Effect on Liver Cancer Cells of Gold Nanoparticles
Modified with Lithocholic Acid. Nanoscale Res Lett 2018; 13: 304 [PMID: 30269179 DOI:
10.1186/s11671-018-2653-8]
165 Marchionatti AM, Pérez A, Rivoira MA, Rodríguez VA, Tolosa de Talamoni NG. Lithocholic acid: a
new emergent protector of intestinal calcium absorption under oxidant conditions. Biochem Cell Biol 2017;
95: 273-279 [PMID: 28318299 DOI: 10.1139/bcb-2016-0164]
166 Rivoira M, Rodríguez V, López MP, Tolosa de Talamoni N. Time dependent changes in the intestinal Ca²
absorption in rats with type I diabetes mellitus are associated with alterations in the intestinal redox state.
Biochim Biophys Acta 2015; 1852: 386-394 [PMID: 25459228 DOI: 10.1016/j.bbadis.2014.11.018]
167 Rodríguez V, Rivoira M, Guizzardi S, Tolosa de Talamoni N. Naringin prevents the inhibition of
intestinal Ca2+ absorption induced by a fructose rich diet. Arch Biochem Biophys 2017; 636: 1-10 [PMID:
29122589 DOI: 10.1016/j.abb.2017.11.002]
168 Bakar E, Ulucam E, Cerkezkayabekir A, Sanal F, Inan M. Investigation of the effects of naringin on
intestinal ischemia reperfusion model at the ultrastructural and biochemical level. Biomed Pharmacother
2019; 109: 345-350 [PMID: 30399568 DOI: 10.1016/j.biopha.2018.10.045]
169 Cao H, Liu J, Shen P, Cai J, Han Y, Zhu K, Fu Y, Zhang N, Zhang Z, Cao Y. Protective Effect of
Naringin on DSS-Induced Ulcerative Colitis in Mice. J Agric Food Chem 2018; 66: 13133-13140 [PMID:
30472831 DOI: 10.1021/acs.jafc.8b03942]
170 Li Z, Gao M, Yang B, Zhang H, Wang K, Liu Z, Xiao X, Yang M. Naringin attenuates MLC
WJG https://www.wjgnet.com June 28, 2020 Volume 26 Issue 24
Areco VA et al. Ca2+ absorption/molecular and clinical approach
3363
phosphorylation and NF-κB activation to protect sepsis-induced intestinal injury via RhoA/ROCK
pathway. Biomed Pharmacother 2018; 103: 50-58 [PMID: 29635128 DOI: 10.1016/j.biopha.2018.03.163]
171 Zhang YS, Li Y, Wang Y, Sun SY, Jiang T, Li C, Cui SX, Qu XJ. Naringin, a natural dietary compound,
prevents intestinal tumorigenesis in Apc (Min/+) mouse model. J Cancer Res Clin Oncol 2016; 142: 913-
925 [PMID: 26702935 DOI: 10.1007/s00432-015-2097-9]
172 Lima ACD, Cecatti C, Fidélix MP, Adorno MAT, Sakamoto IK, Cesar TB, Sivieri K. Effect of Daily
Consumption of Orange Juice on the Levels of Blood Glucose, Lipids, and Gut Microbiota Metabolites:
Controlled Clinical Trials. J Med Food 2019; 22: 202-210 [PMID: 30638420 DOI:
10.1089/jmf.2018.0080]
173 D'Amelio P, Sassi F. Gut Microbiota, Immune System, and Bone. Calcif Tissue Int 2018; 102: 415-425
[PMID: 28965190 DOI: 10.1007/s00223-017-0331-y]
174 Ardizzone S, Cassinotti A, Bevilacqua M, Clerici M, Porro GB. Vitamin D and inflammatory bowel
disease. Vitam Horm 2011; 86: 367-377 [PMID: 21419280 DOI: 10.1016/B978-0-12-386960-9.00016-2]
175 Kumari M, Khazai NB, Ziegler TR, Nanes MS, Abrams SA, Tangpricha V. Vitamin D-mediated calcium
absorption in patients with clinically stable Crohn's disease: a pilot study. Mol Nutr Food Res 2010; 54:
1085-1091 [PMID: 20306476 DOI: 10.1002/mnfr.200900351]
176 Motta ME, Faria ME, Silva GA. Prevalence of low bone mineral density in children and adolescents with
celiac disease under treatment. Sao Paulo Med J 2009; 127: 278-282 [PMID: 20169276 DOI:
10.1590/S1516-31802009000500006]
177 Vasquez H, Mazure R, Gonzalez D, Flores D, Pedreira S, Niveloni S, Smecuol E, Mauriño E, Bai JC. Risk
of fractures in celiac disease patients: a cross-sectional, case-control study. Am J Gastroenterol 2000; 95:
183-189 [PMID: 10638580 DOI: 10.1111/j.1572-0241.2000.01682.x]
178 Hoenderop JG, Nilius B, Bindels RJ. Calcium absorption across epithelia. Physiol Rev 2005; 85: 373-422
[PMID: 15618484 DOI: 10.1152/physrev.00003.2004]
179 Krupa-Kozak U, Drabińska N. Calcium in Gluten-Free Life: Health-Related and Nutritional Implications.
Foods 2016; 5 [PMID: 28231146 DOI: 10.3390/foods5030051]
180 Zanchi C, Di Leo G, Ronfani L, Martelossi S, Not T, Ventura A. Bone metabolism in celiac disease. J
Pediatr 2008; 153: 262-265 [PMID: 18534236 DOI: 10.1016/j.jpeds.2008.03.003]
181 Campanha-Versiani L, Pereira DAG, Ribeiro-Samora GA, Ramos AV, de Sander Diniz MFH, De Marco
LA, Soares MMS. The Effect of a Muscle Weight-Bearing and Aerobic Exercise Program on the Body
Composition, Muscular Strength, Biochemical Markers, and Bone Mass of Obese Patients Who Have
Undergone Gastric Bypass Surgery. Obes Surg 2017; 27: 2129-2137 [PMID: 28285470 DOI:
10.1007/s11695-017-2618-5]
182 Abegg K, Gehring N, Wagner CA, Liesegang A, Schiesser M, Bueter M, Lutz TA. Roux-en-Y gastric
bypass surgery reduces bone mineral density and induces metabolic acidosis in rats. Am J Physiol Regul
Integr Comp Physiol 2013; 305: R999-R1009 [PMID: 24026074 DOI: 10.1152/ajpregu.00038.2013]
183 Chakhtoura MT, Nakhoul NN, Shawwa K, Mantzoros C, El Hajj Fuleihan GA. Hypovitaminosis D in
bariatric surgery: A systematic review of observational studies. Metabolism 2016; 65: 574-585 [PMID:
26805016 DOI: 10.1016/j.metabol.2015.12.004]
184 Corbeels K, Verlinden L, Lannoo M, Simoens C, Matthys C, Verstuyf A, Meulemans A, Carmeliet G,
Van der Schueren B. Thin bones: Vitamin D and calcium handling after bariatric surgery. Bone Rep 2018;
8: 57-63 [PMID: 29955623 DOI: 10.1016/j.bonr.2018.02.002]
185 Riedt CS, Brolin RE, Sherrell RM, Field MP, Shapses SA. True fractional calcium absorption is decreased
after Roux-en-Y gastric bypass surgery. Obesity (Silver Spring) 2006; 14: 1940-1948 [PMID: 17135609
DOI: 10.1038/oby.2006.226]
186 Fleischer J, Stein EM, Bessler M, Della Badia M, Restuccia N, Olivero-Rivera L, McMahon DJ,
Silverberg SJ. The decline in hip bone density after gastric bypass surgery is associated with extent of
weight loss. J Clin Endocrinol Metab 2008; 93: 3735-3740 [PMID: 18647809 DOI:
10.1210/jc.2008-0481]
187 Schneider LE, Schedl HP. Diabetes and intestinal calcium absorption in the rat. Am J Physiol 1972; 223:
1319-1323 [PMID: 4641621 DOI: 10.1152/ajplegacy.1972.223.6.1319]
188 Seino Y, Sierra RI, Sonn YM, Jafari A, Birge SJ, Avioli LV. The duodenal 1 alpha,25-dihydroxyvitamin
D3 receptor in rats with experimentally induced diabetes. Endocrinology 1983; 113: 1721-1725 [PMID:
6354695 DOI: 10.1210/endo-113-5-1721]
189 Nyomba BL, Verhaeghe J, Thomasset M, Lissens W, Bouillon R. Bone mineral homeostasis in
spontaneously diabetic BB rats. I. Abnormal vitamin D metabolism and impaired active intestinal calcium
absorption. Endocrinology 1989; 124: 565-572 [PMID: 2536313 DOI: 10.1210/endo-124-2-565]
190 Weber DR, O'Brien KO, Schwartz GJ. Evidence of disordered calcium metabolism in adolescent girls
with type 1 diabetes: An observational study using a dual-stable calcium isotope technique. Bone 2017;
105: 184-190 [PMID: 28882565 DOI: 10.1016/j.bone.2017.09.001]
191 Grieco GE, Cataldo D, Ceccarelli E, Nigi L, Catalano G, Brusco N, Mancarella F, Ventriglia G, Fondelli
C, Guarino E, Crisci I, Sebastiani G, Dotta F. Serum Levels of miR-148a and miR-21-5p Are Increased in
Type 1 Diabetic Patients and Correlated with Markers of Bone Strength and Metabolism. Noncoding RNA
2018; 4 [PMID: 30486455 DOI: 10.3390/ncrna4040037]
192 Frick KK, Bushinsky DA. Molecular mechanisms of primary hypercalciuria. J Am Soc Nephrol 2003; 14:
1082-1095 [PMID: 12660344 DOI: 10.1097/01.asn.0000062960.26868.17]
193 Wu G, Zhang W, Na T, Jing H, Wu H, Peng JB. Suppression of intestinal calcium entry channel TRPV6
by OCRL, a lipid phosphatase associated with Lowe syndrome and Dent disease. Am J Physiol Cell
Physiol 2012; 302: C1479-C1491 [PMID: 22378746 DOI: 10.1152/ajpcell.00277.2011]
194 Silva IV, Cebotaru V, Wang H, Wang XT, Wang SS, Guo G, Devuyst O, Thakker RV, Guggino WB,
Guggino SE. The ClC-5 knockout mouse model of Dent's disease has renal hypercalciuria and increased
bone turnover. J Bone Miner Res 2003; 18: 615-623 [PMID: 12674322 DOI: 10.1359/jbmr.2003.18.4.615]
195 Bergwitz C, Miyamoto KI. Hereditary hypophosphatemic rickets with hypercalciuria: pathophysiology,
clinical presentation, diagnosis and therapy. Pflugers Arch 2019; 471: 149-163 [PMID: 30109410 DOI:
10.1007/s00424-018-2184-2]
196 Augoulea A, Zachou G, Lambrinoudaki I. Turner syndrome and osteoporosis. Maturitas 2019; 130: 41-49
[PMID: 31706435 DOI: 10.1016/j.maturitas.2019.09.010]
WJG https://www.wjgnet.com June 28, 2020 Volume 26 Issue 24
Areco VA et al. Ca2+ absorption/molecular and clinical approach
3364
Published by Baishideng Publishing Group Inc





© 2020 Baishideng Publishing Group Inc. All rights reserved.
